[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fR2O-bFcSEkWbw2d25fV-W76KOayqulnkjby4aqH_8LI":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":35,"phaseBuckets":86,"rows":93},"Benha University",[4],317,false,55,29,38018,28,178,[14,17,20,22,25,27,30,32],{"name":15,"count":16},"Infertility",9,{"name":18,"count":19},"Pain, Postoperative",8,{"name":21,"count":19},"Eyelid Diseases",{"name":23,"count":24},"Cesarean Section Complications",7,{"name":26,"count":24},"COVID-19",{"name":28,"count":29},"Postoperative Pain",5,{"name":31,"count":29},"Retinal Detachment",{"name":33,"count":34},"Cataract",4,[36,41,46,51,56,61,66,71,76,81],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT06786728","Decongestion Guided By VExUS Score Or Lung Ultrasound For Renal Recovery In Patients With Cardiorenal Syndrome Type -1","2025-07","frusemide",{"nctId":42,"briefTitle":43,"date":44,"intervention":45},"NCT07164781","Effect of Use of Probiotics on Systemic Infection in Critically Ill Patients: a Double Blind, Randomized, Placebo-controlled Trial","2025-09-01","Bacillus clausii",{"nctId":47,"briefTitle":48,"date":49,"intervention":50},"NCT07195097","Sildosin as a Male Contraceptive Non Hormonal","2025-11","Oral intake of sildosin",{"nctId":52,"briefTitle":53,"date":54,"intervention":55},"NCT07509411","Anti-TNFα Therapy for Improving Pregnancy Rates in Endometriosis Patients With Failed ICSI","2025-12-15","TNF-α Inhibitor",{"nctId":57,"briefTitle":58,"date":59,"intervention":60},"NCT07318974","Melatonin Therapy for Improving ICSI Outcomes in Women With Diminished Ovarian Reserve","2026-01","Melatonin",{"nctId":62,"briefTitle":63,"date":64,"intervention":65},"NCT06839391","Effect of Hyaluronidase in Different Doses Added to Bupivacaine on TAB Block Quality During CS","2026-03","Hyaluronidase",{"nctId":67,"briefTitle":68,"date":69,"intervention":70},"NCT07380568","Melatonin on Post Operative Pain After CS","2026-03-01","Melatonin 5 mg",{"nctId":72,"briefTitle":73,"date":74,"intervention":75},"NCT07198412","Effect of Sedation After Ultrasound-Guided Spinal Anesthesia on Back Pain","2026-04-10","Midazolam plus ultrasound-guided spinal anesthesia",{"nctId":77,"briefTitle":78,"date":79,"intervention":80},"NCT07184307","Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial","2026-04-15","Platelet-Rich Plasma",{"nctId":82,"briefTitle":83,"date":84,"intervention":85},"NCT07329933","Dexamethasone, Dexmedetomidine and Their Combination on Post op. GIT Function Measured by I-FFED Score Post Laparoscopic Cholecystectomy","2026-05-01","Dexamethasone",[87,88,89,90,91,92],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[94,171,332,365,386,404,438,460,485,528,567,589,612,630,656,674,692,710,734,752,775,793,821,846,864,887,905,929,947,1001,1028,1046,1070,1088,1113,1137,1162,1195,1230,1256,1274,1299,1317,1342,1360,1387,1405,1430,1457,1475,1493,1511,1536,1554,1578,1604,1622,1640,1666,1684,1709,1727,1753,1778,1803,1830,1848,1874,1892,1910,1934,1958,1980,2007,2025,2043,2068,2086,2110,2128,2151,2177,2203,2221,2239,2265,2283,2309,2335,2373,2391,2409,2427,2452,2470,2495,2513,2540,2558,2576,2624,2661,2689,2726,2759,2787,2822,2850,2888,2925,2953,2978,3006,3024,3053,3071,3095,3120,3138,3164,3189,3207,3232,3250,3274,3301,3328,3346,3370,3392,3419,3437,3461,3485,3503,3521,3539,3565,3583,3609,3627,3645,3671,3689,3715,3739,3757,3781,3806,3824,3842,3870,3888,3906,3931,3949,3976,3994,4018,4036,4062,4080,4106,4124,4149,4167,4185,4203,4227,4245,4263,4289,4307,4333,4351,4375,4393,4418,4445,4470,4494,4512,4537,4555,4573,4600],{"intervention":95,"totalTrials":29,"cells":96},"Bupivacaine",{"EARLY_PHASE1":97,"PHASE1":100,"PHASE2":102,"PHASE3":118,"PHASE4":129,"NA":145},{"trials":98,"activeCount":99},[],0,{"trials":101,"activeCount":99},[],{"trials":103,"activeCount":117,"soonestReadout":109},[104],{"nctId":105,"briefTitle":106,"status":107,"phases":108,"primaryCompletion":109,"completion":110,"start":111,"enrollment":112,"conditions":113,"interventions":115},"NCT07465185","Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery","RECRUITING",[89],"2026-09-15","2026-10-15","2026-03-15",300,[114],"Anesthesia",[95,116],"Bupivacaine and Dexmedetomidine",1,{"trials":119,"activeCount":117,"soonestReadout":124},[120],{"nctId":121,"briefTitle":122,"status":107,"phases":123,"primaryCompletion":124,"completion":109,"start":111,"enrollment":125,"conditions":126,"interventions":128},"NCT07467356","Anterior Iliopsoas Space Block Versus PENG Block on Ease of Positioning for Spinal Anathesia in Patients Undergoing Hip Surgeries",[90],"2026-08-15",90,[127],"Pain Management",[95,95],{"trials":130,"activeCount":99},[131],{"nctId":132,"briefTitle":133,"status":134,"phases":135,"primaryCompletion":136,"completion":137,"start":138,"enrollment":139,"conditions":140,"interventions":143},"NCT04941170","U\u002Fs Guided Oblique Subcostal Transversus Abdominis Plane Block Versus Erector Spinae Plane Block as Preemptive Analgesia","COMPLETED",[91],"2021-11-01","2021-12-15","2021-06-29",70,[141,142],"Pain","Hernia, Umbilical",[144,95],"Bupivacain",{"trials":146,"activeCount":99},[147,161],{"nctId":148,"briefTitle":149,"status":134,"phases":150,"primaryCompletion":151,"completion":152,"start":153,"enrollment":154,"conditions":155,"interventions":157},"NCT04932083","Intrathecal Midazolam, Fentanyl and Nalbuphine as Adjuvants to Bupivacaine in Spinal Anesthesia for Cesarean Section",[92],"2022-01-14","2022-02-24","2021-06-20",100,[156],"Pain, Acute",[95,158,159,160],"Fentanyl","Nalbuphine","Midazolam",{"nctId":162,"briefTitle":163,"status":134,"phases":164,"primaryCompletion":165,"completion":166,"start":167,"enrollment":168,"conditions":169,"interventions":170},"NCT05671172","Effect of Adding Hyaluronidase to Bupivacaine in Transversus Abdominis Plane Block for Cesarean Section",[92],"2024-01-10","2024-02-10","2023-05-15",114,[18],[65,95],{"intervention":172,"totalTrials":173,"cells":174},"Dexmedetomidine",12,{"EARLY_PHASE1":175,"PHASE1":177,"PHASE2":179,"PHASE3":204,"PHASE4":206,"NA":220},{"trials":176,"activeCount":99},[],{"trials":178,"activeCount":99},[],{"trials":180,"activeCount":117,"soonestReadout":197},[181,193],{"nctId":182,"briefTitle":183,"status":134,"phases":184,"primaryCompletion":185,"completion":186,"start":187,"enrollment":188,"conditions":189,"interventions":191},"NCT04949477","Intranasal Dexmedetomidine Versus Oral Paracetamol as a Pre-anaesthetic Medication in Pediatric Age Group",[89],"2021-12-01","2022-01-01","2021-07-01",86,[190],"Anxiety",[172,192],"paracetamol",{"nctId":194,"briefTitle":195,"status":107,"phases":196,"primaryCompletion":197,"completion":198,"start":199,"enrollment":200,"conditions":201,"interventions":203},"NCT07443085","Effect of Dexmedetomidine Dosage on Postoperative Delirium in Geriatric Orthopedic Surgery",[89],"2027-07","2027-10","2026-02-26",75,[202],"Delirium - Postoperative",[172,172,158],{"trials":205,"activeCount":99},[],{"trials":207,"activeCount":99},[208],{"nctId":209,"briefTitle":210,"status":134,"phases":211,"primaryCompletion":212,"completion":213,"start":214,"enrollment":215,"conditions":216,"interventions":218},"NCT05951387","Dexmedetomidine Versus Dexmedetomidine with Ketamine in Mechanically Ventilated ARDS Patients",[91],"2024-06-01","2024-06-05","2023-06-01",60,[217],"Haemodynamic Instability",[219,172],"dexmedetomidine plus ketamine",{"trials":221,"activeCount":34,"soonestReadout":84},[222,235,249,261,275,288,297,308,319],{"nctId":223,"briefTitle":224,"status":134,"phases":225,"primaryCompletion":226,"completion":227,"start":228,"enrollment":229,"conditions":230,"interventions":233},"NCT05610774","Optic Nerve Sheath Diameter in Pre-Eclamptic Parturient Receiving Magnesium Sulfate Combined With Dexmedetomidine",[92],"2024-05-10","2024-06-15","2023-06-06",50,[231,232],"Preeclampsia Severe","Optic Nerve Sheath Diameter",[172,234],"Saline",{"nctId":236,"briefTitle":237,"status":238,"phases":239,"primaryCompletion":240,"completion":240,"start":241,"enrollment":242,"conditions":243,"interventions":247},"NCT06993194","Comparison of Haloperidol and Dexmedetomidine for Delirium and Agitation in ICU Patients With Traumatic Brain Injury","NOT_YET_RECRUITING",[92],"2026-06-15","2025-06-15",40,[244,245,246],"Traumatic Brain Injury","Delirium","Agitation",[248,172],"Haloperidol",{"nctId":250,"briefTitle":251,"status":238,"phases":252,"primaryCompletion":253,"completion":254,"start":255,"enrollment":256,"conditions":257,"interventions":259},"NCT07326332","Effect of Dexmedetomidine on Tear Production in Angioplasty Patients",[92],"2026-06-01","2026-06-20","2026-01-01",52,[258],"Tear Film Alteration",[172,260],"Sedation with Midazolam, Fentanyl, and Propofol",{"nctId":262,"briefTitle":263,"status":107,"phases":264,"primaryCompletion":265,"completion":265,"start":266,"enrollment":256,"conditions":267,"interventions":274},"NCT07343843","Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section",[92],"2026-07-01","2026-01-17",[268,172,269,270,271,272,273],"Virtual Reality","Maternal Anxiety","Stress","Hemodynamics","Neonatal Outcomes","Cesarean Section",[172],{"nctId":276,"briefTitle":277,"status":278,"phases":279,"primaryCompletion":280,"completion":281,"start":282,"enrollment":283,"conditions":284,"interventions":286},"NCT06423859","Articaine Plus Dexmedetomidine in Supraclavicular Block","UNKNOWN",[92],"2024-08-01","2024-08-20","2024-02-01",66,[285],"Post Operative Pain, Acute",[287,172],"Articaine",{"nctId":82,"briefTitle":83,"status":238,"phases":289,"primaryCompletion":84,"completion":253,"start":54,"enrollment":290,"conditions":291,"interventions":295},[92],160,[292,293,85,172,294],"GIT Function","Cholecystectomy, Laparoscopic","I-FEED Score",[85,172,296],"Dexamethasone and dexmedetomidine",{"nctId":298,"briefTitle":299,"status":134,"phases":300,"primaryCompletion":301,"completion":302,"start":303,"enrollment":200,"conditions":304,"interventions":305},"NCT06662318","Perioperative Pain Management for Lumbar Spine Surgery",[92],"2024-12-30","2025-01-15","2024-10-01",[18],[306,172,307],"Fentanyl Citrate","Lidocaine Hydrochloride",{"nctId":309,"briefTitle":310,"status":134,"phases":311,"primaryCompletion":312,"completion":313,"start":314,"enrollment":200,"conditions":315,"interventions":317},"NCT06907277","Dexmedetomidine Enhancing the Recovery After Cardiac Surgery",[92],"2024-12-01","2025-01-31","2024-08-30",[316],"Post-cardiac Surgery",[172,158,318],"Lidocain",{"nctId":320,"briefTitle":321,"status":134,"phases":322,"primaryCompletion":323,"completion":324,"start":325,"enrollment":326,"conditions":327,"interventions":329},"NCT07497009","Effect of Lidocaine Infusion Versus Dexmedemidine Infusion on the Neurocognitive Function of Elderly Patients Undergoing Endoscopic Retrograde Cholangiopancreatography(ERCP).",[92],"2025-04-23","2025-08-23","2024-12-23",30,[328],"Neurocognitive Function of Elderly Patients",[172,330,331],"lidocaine","normal saline",{"intervention":60,"totalTrials":333,"cells":334},2,{"EARLY_PHASE1":335,"PHASE1":337,"PHASE2":339,"PHASE3":349,"PHASE4":351,"NA":353},{"trials":336,"activeCount":99},[],{"trials":338,"activeCount":99},[],{"trials":340,"activeCount":117,"soonestReadout":59},[341],{"nctId":57,"briefTitle":58,"status":342,"phases":343,"primaryCompletion":59,"completion":64,"start":344,"enrollment":345,"conditions":346,"interventions":348},"ACTIVE_NOT_RECRUITING",[89],"2025-09-10",64,[347],"ICS",[60],{"trials":350,"activeCount":99},[],{"trials":352,"activeCount":99},[],{"trials":354,"activeCount":117,"soonestReadout":84},[355],{"nctId":356,"briefTitle":357,"status":358,"phases":359,"primaryCompletion":84,"completion":253,"start":360,"enrollment":361,"conditions":362,"interventions":364},"NCT07375342","Melatonin for Post Tonsillectomy Emergence Agitation in Pediatric","ENROLLING_BY_INVITATION",[92],"2025-12-10",120,[363],"Post Tonsillectomy Emergence Agitation",[60],{"intervention":55,"totalTrials":117,"cells":366},{"EARLY_PHASE1":367,"PHASE1":369,"PHASE2":371,"PHASE3":380,"PHASE4":382,"NA":384},{"trials":368,"activeCount":99},[],{"trials":370,"activeCount":99},[],{"trials":372,"activeCount":117,"soonestReadout":54},[373],{"nctId":52,"briefTitle":53,"status":342,"phases":374,"primaryCompletion":54,"completion":110,"start":375,"enrollment":376,"conditions":377,"interventions":379},[89],"2025-08-15",145,[378],"Endometriosis",[55],{"trials":381,"activeCount":99},[],{"trials":383,"activeCount":99},[],{"trials":385,"activeCount":99},[],{"intervention":116,"totalTrials":117,"cells":387},{"EARLY_PHASE1":388,"PHASE1":390,"PHASE2":392,"PHASE3":398,"PHASE4":400,"NA":402},{"trials":389,"activeCount":99},[],{"trials":391,"activeCount":99},[],{"trials":393,"activeCount":117,"soonestReadout":109},[394],{"nctId":105,"briefTitle":106,"status":107,"phases":395,"primaryCompletion":109,"completion":110,"start":111,"enrollment":112,"conditions":396,"interventions":397},[89],[114],[95,116],{"trials":399,"activeCount":99},[],{"trials":401,"activeCount":99},[],{"trials":403,"activeCount":99},[],{"intervention":158,"totalTrials":34,"cells":405},{"EARLY_PHASE1":406,"PHASE1":408,"PHASE2":410,"PHASE3":416,"PHASE4":426,"NA":428},{"trials":407,"activeCount":99},[],{"trials":409,"activeCount":99},[],{"trials":411,"activeCount":117,"soonestReadout":197},[412],{"nctId":194,"briefTitle":195,"status":107,"phases":413,"primaryCompletion":197,"completion":198,"start":199,"enrollment":200,"conditions":414,"interventions":415},[89],[202],[172,172,158],{"trials":417,"activeCount":99},[418],{"nctId":419,"briefTitle":420,"status":134,"phases":421,"primaryCompletion":255,"completion":255,"start":422,"enrollment":215,"conditions":423,"interventions":424},"NCT07350668","Opioid-Free vs Opioid-Based Anesthesia for Nasal Surgeries",[90],"2025-01-01",[28],[425,158],"dexmedetomidine and lignocaine",{"trials":427,"activeCount":99},[],{"trials":429,"activeCount":99},[430,434],{"nctId":148,"briefTitle":149,"status":134,"phases":431,"primaryCompletion":151,"completion":152,"start":153,"enrollment":154,"conditions":432,"interventions":433},[92],[156],[95,158,159,160],{"nctId":309,"briefTitle":310,"status":134,"phases":435,"primaryCompletion":312,"completion":313,"start":314,"enrollment":200,"conditions":436,"interventions":437},[92],[316],[172,158,318],{"intervention":50,"totalTrials":117,"cells":439},{"EARLY_PHASE1":440,"PHASE1":442,"PHASE2":452,"PHASE3":454,"PHASE4":456,"NA":458},{"trials":441,"activeCount":99},[],{"trials":443,"activeCount":117,"soonestReadout":49},[444],{"nctId":47,"briefTitle":48,"status":238,"phases":445,"primaryCompletion":49,"completion":446,"start":447,"enrollment":448,"conditions":449,"interventions":451},[88],"2025-12","2025-09",200,[450],"Contraception Use",[50],{"trials":453,"activeCount":99},[],{"trials":455,"activeCount":99},[],{"trials":457,"activeCount":99},[],{"trials":459,"activeCount":99},[],{"intervention":65,"totalTrials":333,"cells":461},{"EARLY_PHASE1":462,"PHASE1":471,"PHASE2":473,"PHASE3":475,"PHASE4":477,"NA":479},{"trials":463,"activeCount":117,"soonestReadout":64},[464],{"nctId":62,"briefTitle":63,"status":238,"phases":465,"primaryCompletion":64,"completion":466,"start":467,"enrollment":361,"conditions":468,"interventions":470},[87],"2026-04","2025-03",[469],"Tab Block Qaulity",[65],{"trials":472,"activeCount":99},[],{"trials":474,"activeCount":99},[],{"trials":476,"activeCount":99},[],{"trials":478,"activeCount":99},[],{"trials":480,"activeCount":99},[481],{"nctId":162,"briefTitle":163,"status":134,"phases":482,"primaryCompletion":165,"completion":166,"start":167,"enrollment":168,"conditions":483,"interventions":484},[92],[18],[65,95],{"intervention":85,"totalTrials":486,"cells":487},3,{"EARLY_PHASE1":488,"PHASE1":490,"PHASE2":492,"PHASE3":505,"PHASE4":507,"NA":509},{"trials":489,"activeCount":99},[],{"trials":491,"activeCount":99},[],{"trials":493,"activeCount":99},[494],{"nctId":495,"briefTitle":496,"status":134,"phases":497,"primaryCompletion":498,"completion":499,"start":500,"enrollment":125,"conditions":501,"interventions":503},"NCT05143762","Preemptive Dexamethasone , Paracetamol on Postoperative Period Following Adeno-tonsillectomy in Pediatric .",[89],"2022-03-01","2022-04-01","2021-10-15",[502],"Analgesia",[192,85,504],"normal Saline",{"trials":506,"activeCount":99},[],{"trials":508,"activeCount":99},[],{"trials":510,"activeCount":117,"soonestReadout":84},[511,524],{"nctId":512,"briefTitle":513,"status":134,"phases":514,"primaryCompletion":515,"completion":516,"start":517,"enrollment":518,"conditions":519,"interventions":521},"NCT06537518","The Difference Between Using Local and General Dexamethasone in Arthroscopic Anterior Cruciate Ligament Repair",[92],"2022-11-20","2022-12-25","2022-05-01",123,[520],"ACL Injury",[85,522,523],"Bupivacaine 0.375% Injectable Solution","Bupivacaine 0.5% Injectable Solution",{"nctId":82,"briefTitle":83,"status":238,"phases":525,"primaryCompletion":84,"completion":253,"start":54,"enrollment":290,"conditions":526,"interventions":527},[92],[292,293,85,172,294],[85,172,296],{"intervention":529,"totalTrials":333,"cells":530},"botulinum toxin type A",{"EARLY_PHASE1":531,"PHASE1":546,"PHASE2":548,"PHASE3":550,"PHASE4":552,"NA":554},{"trials":532,"activeCount":99},[533],{"nctId":534,"briefTitle":535,"status":278,"phases":536,"primaryCompletion":537,"completion":538,"start":539,"enrollment":540,"conditions":541,"interventions":544},"NCT04467450","Ultrasound Guided Botulinum Toxin Type A Injection of Subacromial-Subdeltoid Bursa in Hemiplegic Shoulder Pain",[87],"2020-11-20","2020-12-15","2020-06-01",36,[542,543],"Subacromial Bursitis","Subdeltoid Bursitis",[529,545],"Methyl Prednisolonate",{"trials":547,"activeCount":99},[],{"trials":549,"activeCount":99},[],{"trials":551,"activeCount":99},[],{"trials":553,"activeCount":99},[],{"trials":555,"activeCount":117,"soonestReadout":560},[556],{"nctId":557,"briefTitle":558,"status":238,"phases":559,"primaryCompletion":560,"completion":560,"start":54,"enrollment":561,"conditions":562,"interventions":564},"NCT07236632","Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized Study",[92],"2026-12-15",80,[563],"Premature Ejaculation",[565,566],"Botulinum toxin type A","Hyaluronic acid",{"intervention":40,"totalTrials":117,"cells":568},{"EARLY_PHASE1":569,"PHASE1":571,"PHASE2":573,"PHASE3":575,"PHASE4":577,"NA":579},{"trials":570,"activeCount":99},[],{"trials":572,"activeCount":99},[],{"trials":574,"activeCount":99},[],{"trials":576,"activeCount":99},[],{"trials":578,"activeCount":99},[],{"trials":580,"activeCount":117,"soonestReadout":39},[581],{"nctId":37,"briefTitle":38,"status":358,"phases":582,"primaryCompletion":39,"completion":583,"start":584,"enrollment":585,"conditions":586,"interventions":588},[92],"2025-08","2024-08-10",146,[587],"Cardiorenal Syndrome Type 1",[40],{"intervention":590,"totalTrials":117,"cells":591},"Palmitoylethanolamide",{"EARLY_PHASE1":592,"PHASE1":594,"PHASE2":596,"PHASE3":598,"PHASE4":600,"NA":602},{"trials":593,"activeCount":99},[],{"trials":595,"activeCount":99},[],{"trials":597,"activeCount":99},[],{"trials":599,"activeCount":99},[],{"trials":601,"activeCount":99},[],{"trials":603,"activeCount":117,"soonestReadout":253},[604],{"nctId":605,"briefTitle":606,"status":238,"phases":607,"primaryCompletion":253,"completion":265,"start":255,"enrollment":361,"conditions":608,"interventions":610},"NCT07316660","Palmitoylethanolamide vs Ibuprofen for Pain After ESWL",[92],[609,590],"Pain After Extracorporeal Shock Wave Lithotripsy",[590,611],"Ibuprofen",{"intervention":611,"totalTrials":117,"cells":613},{"EARLY_PHASE1":614,"PHASE1":616,"PHASE2":618,"PHASE3":620,"PHASE4":622,"NA":624},{"trials":615,"activeCount":99},[],{"trials":617,"activeCount":99},[],{"trials":619,"activeCount":99},[],{"trials":621,"activeCount":99},[],{"trials":623,"activeCount":99},[],{"trials":625,"activeCount":117,"soonestReadout":253},[626],{"nctId":605,"briefTitle":606,"status":238,"phases":627,"primaryCompletion":253,"completion":265,"start":255,"enrollment":361,"conditions":628,"interventions":629},[92],[609,590],[590,611],{"intervention":631,"totalTrials":117,"cells":632},"Caudal Bupivacaine",{"EARLY_PHASE1":633,"PHASE1":635,"PHASE2":637,"PHASE3":639,"PHASE4":641,"NA":643},{"trials":634,"activeCount":99},[],{"trials":636,"activeCount":99},[],{"trials":638,"activeCount":99},[],{"trials":640,"activeCount":99},[],{"trials":642,"activeCount":99},[],{"trials":644,"activeCount":117,"soonestReadout":649},[645],{"nctId":646,"briefTitle":647,"status":238,"phases":648,"primaryCompletion":649,"completion":650,"start":651,"enrollment":229,"conditions":652,"interventions":654},"NCT05902780","Can Caudal Dexmedetomidine Provide Effective Analgesia?",[92],"2027-09-01","2027-10-01","2024-09-01",[114,653],"Local Anesthesia",[631,655],"Caudal Dexmedetomidine",{"intervention":655,"totalTrials":117,"cells":657},{"EARLY_PHASE1":658,"PHASE1":660,"PHASE2":662,"PHASE3":664,"PHASE4":666,"NA":668},{"trials":659,"activeCount":99},[],{"trials":661,"activeCount":99},[],{"trials":663,"activeCount":99},[],{"trials":665,"activeCount":99},[],{"trials":667,"activeCount":99},[],{"trials":669,"activeCount":117,"soonestReadout":649},[670],{"nctId":646,"briefTitle":647,"status":238,"phases":671,"primaryCompletion":649,"completion":650,"start":651,"enrollment":229,"conditions":672,"interventions":673},[92],[114,653],[631,655],{"intervention":248,"totalTrials":117,"cells":675},{"EARLY_PHASE1":676,"PHASE1":678,"PHASE2":680,"PHASE3":682,"PHASE4":684,"NA":686},{"trials":677,"activeCount":99},[],{"trials":679,"activeCount":99},[],{"trials":681,"activeCount":99},[],{"trials":683,"activeCount":99},[],{"trials":685,"activeCount":99},[],{"trials":687,"activeCount":117,"soonestReadout":240},[688],{"nctId":236,"briefTitle":237,"status":238,"phases":689,"primaryCompletion":240,"completion":240,"start":241,"enrollment":242,"conditions":690,"interventions":691},[92],[244,245,246],[248,172],{"intervention":260,"totalTrials":117,"cells":693},{"EARLY_PHASE1":694,"PHASE1":696,"PHASE2":698,"PHASE3":700,"PHASE4":702,"NA":704},{"trials":695,"activeCount":99},[],{"trials":697,"activeCount":99},[],{"trials":699,"activeCount":99},[],{"trials":701,"activeCount":99},[],{"trials":703,"activeCount":99},[],{"trials":705,"activeCount":117,"soonestReadout":253},[706],{"nctId":250,"briefTitle":251,"status":238,"phases":707,"primaryCompletion":253,"completion":254,"start":255,"enrollment":256,"conditions":708,"interventions":709},[92],[258],[172,260],{"intervention":80,"totalTrials":117,"cells":711},{"EARLY_PHASE1":712,"PHASE1":714,"PHASE2":716,"PHASE3":718,"PHASE4":720,"NA":722},{"trials":713,"activeCount":99},[],{"trials":715,"activeCount":99},[],{"trials":717,"activeCount":99},[],{"trials":719,"activeCount":99},[],{"trials":721,"activeCount":99},[],{"trials":723,"activeCount":117,"soonestReadout":79},[724],{"nctId":77,"briefTitle":78,"status":107,"phases":725,"primaryCompletion":79,"completion":79,"start":726,"enrollment":727,"conditions":728,"interventions":732},[92],"2025-04-15",48,[729,730,731],"Overactive Bladder Syndrome","Urinary Urge Incontinence","Detrusor Overactivity",[80,733],"Intravesical Botulinum Toxin",{"intervention":733,"totalTrials":117,"cells":735},{"EARLY_PHASE1":736,"PHASE1":738,"PHASE2":740,"PHASE3":742,"PHASE4":744,"NA":746},{"trials":737,"activeCount":99},[],{"trials":739,"activeCount":99},[],{"trials":741,"activeCount":99},[],{"trials":743,"activeCount":99},[],{"trials":745,"activeCount":99},[],{"trials":747,"activeCount":117,"soonestReadout":79},[748],{"nctId":77,"briefTitle":78,"status":107,"phases":749,"primaryCompletion":79,"completion":79,"start":726,"enrollment":727,"conditions":750,"interventions":751},[92],[729,730,731],[80,733],{"intervention":70,"totalTrials":117,"cells":753},{"EARLY_PHASE1":754,"PHASE1":756,"PHASE2":758,"PHASE3":760,"PHASE4":762,"NA":764},{"trials":755,"activeCount":99},[],{"trials":757,"activeCount":99},[],{"trials":759,"activeCount":99},[],{"trials":761,"activeCount":99},[],{"trials":763,"activeCount":99},[],{"trials":765,"activeCount":117,"soonestReadout":69},[766],{"nctId":67,"briefTitle":68,"status":107,"phases":767,"primaryCompletion":69,"completion":768,"start":769,"enrollment":215,"conditions":770,"interventions":773},[92],"2026-04-01","2025-10-10",[127,771,772],"Pain After Surgery","Cesarean Section Pain",[70,774],"Melatonin 10 mg",{"intervention":774,"totalTrials":117,"cells":776},{"EARLY_PHASE1":777,"PHASE1":779,"PHASE2":781,"PHASE3":783,"PHASE4":785,"NA":787},{"trials":778,"activeCount":99},[],{"trials":780,"activeCount":99},[],{"trials":782,"activeCount":99},[],{"trials":784,"activeCount":99},[],{"trials":786,"activeCount":99},[],{"trials":788,"activeCount":117,"soonestReadout":69},[789],{"nctId":67,"briefTitle":68,"status":107,"phases":790,"primaryCompletion":69,"completion":768,"start":769,"enrollment":215,"conditions":791,"interventions":792},[92],[127,771,772],[70,774],{"intervention":794,"totalTrials":117,"cells":795},"Calcium and Vitamin D Supplementation",{"EARLY_PHASE1":796,"PHASE1":798,"PHASE2":800,"PHASE3":802,"PHASE4":804,"NA":806},{"trials":797,"activeCount":99},[],{"trials":799,"activeCount":99},[],{"trials":801,"activeCount":99},[],{"trials":803,"activeCount":99},[],{"trials":805,"activeCount":99},[],{"trials":807,"activeCount":117,"soonestReadout":812},[808],{"nctId":809,"briefTitle":810,"status":107,"phases":811,"primaryCompletion":812,"completion":813,"start":255,"enrollment":215,"conditions":814,"interventions":820},"NCT07334626","Impact of Pilates Exercises on Bone Mineral Density in Breast Cancer Survivors Receiving Hormonal Therapy",[92],"2026-07-30","2026-09-30",[815,816,817,818,819],"Breast Cancer","Breast Cancer Survivors","Aromatase Inhibitors","Osteoporosis or Osteopenia","Pilates Exercise",[794],{"intervention":45,"totalTrials":117,"cells":822},{"EARLY_PHASE1":823,"PHASE1":825,"PHASE2":827,"PHASE3":829,"PHASE4":831,"NA":833},{"trials":824,"activeCount":99},[],{"trials":826,"activeCount":99},[],{"trials":828,"activeCount":99},[],{"trials":830,"activeCount":99},[],{"trials":832,"activeCount":99},[],{"trials":834,"activeCount":117,"soonestReadout":44},[835],{"nctId":42,"briefTitle":43,"status":358,"phases":836,"primaryCompletion":44,"completion":837,"start":838,"enrollment":154,"conditions":839,"interventions":845},[92],"2025-12-02","2025-04-01",[840,841,842,843,844],"Ventilator Acquired Pneumonia","Catheter Related Bloodstream Infection","Urinary Tract Infection","Diarrhea","Probiotics",[45],{"intervention":566,"totalTrials":117,"cells":847},{"EARLY_PHASE1":848,"PHASE1":850,"PHASE2":852,"PHASE3":854,"PHASE4":856,"NA":858},{"trials":849,"activeCount":99},[],{"trials":851,"activeCount":99},[],{"trials":853,"activeCount":99},[],{"trials":855,"activeCount":99},[],{"trials":857,"activeCount":99},[],{"trials":859,"activeCount":117,"soonestReadout":560},[860],{"nctId":557,"briefTitle":558,"status":238,"phases":861,"primaryCompletion":560,"completion":560,"start":54,"enrollment":561,"conditions":862,"interventions":863},[92],[563],[565,566],{"intervention":75,"totalTrials":117,"cells":865},{"EARLY_PHASE1":866,"PHASE1":868,"PHASE2":870,"PHASE3":872,"PHASE4":874,"NA":876},{"trials":867,"activeCount":99},[],{"trials":869,"activeCount":99},[],{"trials":871,"activeCount":99},[],{"trials":873,"activeCount":99},[],{"trials":875,"activeCount":99},[],{"trials":877,"activeCount":117,"soonestReadout":74},[878],{"nctId":72,"briefTitle":73,"status":107,"phases":879,"primaryCompletion":74,"completion":880,"start":881,"enrollment":882,"conditions":883,"interventions":886},[92],"2026-05-10","2025-10-01",180,[127,884,885],"Postoperative Acute Pain","Chronic Back Pain",[75],{"intervention":296,"totalTrials":117,"cells":888},{"EARLY_PHASE1":889,"PHASE1":891,"PHASE2":893,"PHASE3":895,"PHASE4":897,"NA":899},{"trials":890,"activeCount":99},[],{"trials":892,"activeCount":99},[],{"trials":894,"activeCount":99},[],{"trials":896,"activeCount":99},[],{"trials":898,"activeCount":99},[],{"trials":900,"activeCount":117,"soonestReadout":84},[901],{"nctId":82,"briefTitle":83,"status":238,"phases":902,"primaryCompletion":84,"completion":253,"start":54,"enrollment":290,"conditions":903,"interventions":904},[92],[292,293,85,172,294],[85,172,296],{"intervention":906,"totalTrials":117,"cells":907},"Vitamin B Complex",{"EARLY_PHASE1":908,"PHASE1":910,"PHASE2":912,"PHASE3":914,"PHASE4":916,"NA":918},{"trials":909,"activeCount":99},[],{"trials":911,"activeCount":99},[],{"trials":913,"activeCount":99},[],{"trials":915,"activeCount":99},[],{"trials":917,"activeCount":99},[],{"trials":919,"activeCount":117,"soonestReadout":84},[920],{"nctId":921,"briefTitle":922,"status":238,"phases":923,"primaryCompletion":84,"completion":84,"start":924,"enrollment":125,"conditions":925,"interventions":927},"NCT06857734","Analgesic and Anti-inflamatory Effect of Vit. B",[92],"2025-03-01",[926],"Postoperative Pain, Acute",[906,928],"vitamin C",{"intervention":928,"totalTrials":117,"cells":930},{"EARLY_PHASE1":931,"PHASE1":933,"PHASE2":935,"PHASE3":937,"PHASE4":939,"NA":941},{"trials":932,"activeCount":99},[],{"trials":934,"activeCount":99},[],{"trials":936,"activeCount":99},[],{"trials":938,"activeCount":99},[],{"trials":940,"activeCount":99},[],{"trials":942,"activeCount":117,"soonestReadout":84},[943],{"nctId":921,"briefTitle":922,"status":238,"phases":944,"primaryCompletion":84,"completion":84,"start":924,"enrollment":125,"conditions":945,"interventions":946},[92],[926],[906,928],{"intervention":144,"totalTrials":29,"cells":948},{"EARLY_PHASE1":949,"PHASE1":951,"PHASE2":953,"PHASE3":965,"PHASE4":976,"NA":999},{"trials":950,"activeCount":99},[],{"trials":952,"activeCount":99},[],{"trials":954,"activeCount":99},[955],{"nctId":956,"briefTitle":957,"status":134,"phases":958,"primaryCompletion":44,"completion":881,"start":959,"enrollment":960,"conditions":961,"interventions":963},"NCT06034873","Ultrasound Guided Pericapsular Nerve Block Versus iv Sedation Analgesia in Reduction of Shoulder Dislocation",[89],"2023-11-15",42,[962],"Perioperative Pain",[964,144],"Propofol injection and fentanyl",{"trials":966,"activeCount":99},[967],{"nctId":968,"briefTitle":969,"status":134,"phases":970,"primaryCompletion":971,"completion":972,"start":422,"enrollment":229,"conditions":973,"interventions":975},"NCT06721832","The Effect of High-thoracic Erector Spinae Plane Block on Postoperative Pain and Diaphragmatic Function in Posterior Cervical Spine Surgery",[90],"2025-05-01","2025-06-01",[974,127],"Cervical Spine Surgery",[144],{"trials":977,"activeCount":99},[978,982,989],{"nctId":132,"briefTitle":133,"status":134,"phases":979,"primaryCompletion":136,"completion":137,"start":138,"enrollment":139,"conditions":980,"interventions":981},[91],[141,142],[144,95],{"nctId":983,"briefTitle":984,"status":134,"phases":985,"primaryCompletion":136,"completion":137,"start":986,"enrollment":215,"conditions":987,"interventions":988},"NCT04943549","Erector Spinae Plane Block Impact on Quality of Recovery After Lumbar Spinal Decompression",[91],"2021-06-01",[28],[144],{"nctId":990,"briefTitle":991,"status":134,"phases":992,"primaryCompletion":993,"completion":994,"start":995,"enrollment":996,"conditions":997,"interventions":998},"NCT05788458","Effect of Bupivacaine Concentration on Ultrasound Guided Pericapsular Group Nerve Block Efficacy in Hip Surgery Patients",[91],"2023-10-01","2023-11-01","2023-04-01",135,[962],[144],{"trials":1000,"activeCount":99},[],{"intervention":1002,"totalTrials":117,"cells":1003},"Budesonide buffered with 0.9% isotonic saline.",{"EARLY_PHASE1":1004,"PHASE1":1006,"PHASE2":1008,"PHASE3":1010,"PHASE4":1012,"NA":1026},{"trials":1005,"activeCount":99},[],{"trials":1007,"activeCount":99},[],{"trials":1009,"activeCount":99},[],{"trials":1011,"activeCount":99},[],{"trials":1013,"activeCount":99},[1014],{"nctId":1015,"briefTitle":1016,"status":134,"phases":1017,"primaryCompletion":1018,"completion":1019,"start":1020,"enrollment":1021,"conditions":1022,"interventions":1024},"NCT06858423","Budesonide Nasal Irrigation Versus Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis Patients",[91],"2024-03-31","2024-05-31","2023-08-15",360,[1023],"Nasal Allergy",[1002,1025],"Fluticasone propionate nasal spray.",{"trials":1027,"activeCount":99},[],{"intervention":1025,"totalTrials":117,"cells":1029},{"EARLY_PHASE1":1030,"PHASE1":1032,"PHASE2":1034,"PHASE3":1036,"PHASE4":1038,"NA":1044},{"trials":1031,"activeCount":99},[],{"trials":1033,"activeCount":99},[],{"trials":1035,"activeCount":99},[],{"trials":1037,"activeCount":99},[],{"trials":1039,"activeCount":99},[1040],{"nctId":1015,"briefTitle":1016,"status":134,"phases":1041,"primaryCompletion":1018,"completion":1019,"start":1020,"enrollment":1021,"conditions":1042,"interventions":1043},[91],[1023],[1002,1025],{"trials":1045,"activeCount":99},[],{"intervention":1047,"totalTrials":117,"cells":1048},"Xiidra 5% Ophthalmic Solution",{"EARLY_PHASE1":1049,"PHASE1":1051,"PHASE2":1053,"PHASE3":1055,"PHASE4":1057,"NA":1068},{"trials":1050,"activeCount":99},[],{"trials":1052,"activeCount":99},[],{"trials":1054,"activeCount":99},[],{"trials":1056,"activeCount":99},[],{"trials":1058,"activeCount":99},[1059],{"nctId":1060,"briefTitle":1061,"status":278,"phases":1062,"primaryCompletion":1063,"completion":1063,"start":1064,"enrollment":242,"conditions":1065,"interventions":1067},"NCT05045053","Efficacy of Xiidra in Dry Eye Disease After Collagen Cross Linking",[91],"2022-01","2021-02-01",[1066],"Corneal Disease",[1047],{"trials":1069,"activeCount":99},[],{"intervention":219,"totalTrials":117,"cells":1071},{"EARLY_PHASE1":1072,"PHASE1":1074,"PHASE2":1076,"PHASE3":1078,"PHASE4":1080,"NA":1086},{"trials":1073,"activeCount":99},[],{"trials":1075,"activeCount":99},[],{"trials":1077,"activeCount":99},[],{"trials":1079,"activeCount":99},[],{"trials":1081,"activeCount":99},[1082],{"nctId":209,"briefTitle":210,"status":134,"phases":1083,"primaryCompletion":212,"completion":213,"start":214,"enrollment":215,"conditions":1084,"interventions":1085},[91],[217],[219,172],{"trials":1087,"activeCount":99},[],{"intervention":1089,"totalTrials":117,"cells":1090},"Ketamine",{"EARLY_PHASE1":1091,"PHASE1":1093,"PHASE2":1095,"PHASE3":1097,"PHASE4":1099,"NA":1111},{"trials":1092,"activeCount":99},[],{"trials":1094,"activeCount":99},[],{"trials":1096,"activeCount":99},[],{"trials":1098,"activeCount":99},[],{"trials":1100,"activeCount":99},[1101],{"nctId":1102,"briefTitle":1103,"status":134,"phases":1104,"primaryCompletion":44,"completion":1105,"start":1106,"enrollment":1107,"conditions":1108,"interventions":1110},"NCT06060210","Impact of Ketamine On Depressive Symptoms In Patients Undergoing Lumbo-peritoneal Shunt Insertion",[91],"2025-11-01","2023-10-29",110,[1109],"Depression, Anxiety",[504,1089],{"trials":1112,"activeCount":99},[],{"intervention":1114,"totalTrials":117,"cells":1115},"Esmolol",{"EARLY_PHASE1":1116,"PHASE1":1118,"PHASE2":1120,"PHASE3":1122,"PHASE4":1124,"NA":1135},{"trials":1117,"activeCount":99},[],{"trials":1119,"activeCount":99},[],{"trials":1121,"activeCount":99},[],{"trials":1123,"activeCount":99},[],{"trials":1125,"activeCount":99},[1126],{"nctId":1127,"briefTitle":1128,"status":134,"phases":1129,"primaryCompletion":1130,"completion":1131,"start":1132,"enrollment":215,"conditions":1133,"interventions":1134},"NCT04752111","Dose Esmolol Infusion Have an Adjuvant Effect to TAP Block for Pain Control in Laparoscopic Cholecystectomy.",[91],"2021-06-15","2021-07-20","2021-01-19",[28],[1114],{"trials":1136,"activeCount":99},[],{"intervention":1138,"totalTrials":117,"cells":1139},"Brolucizumab-Dbll",{"EARLY_PHASE1":1140,"PHASE1":1142,"PHASE2":1144,"PHASE3":1146,"PHASE4":1148,"NA":1160},{"trials":1141,"activeCount":99},[],{"trials":1143,"activeCount":99},[],{"trials":1145,"activeCount":99},[],{"trials":1147,"activeCount":99},[],{"trials":1149,"activeCount":99},[1150],{"nctId":1151,"briefTitle":1152,"status":278,"phases":1153,"primaryCompletion":516,"completion":1154,"start":1155,"enrollment":1156,"conditions":1157,"interventions":1159},"NCT04690062","BEOVU in the Treatment of Dystrophy-related Macular Neovascular Degeneration",[91],"2022-12-30","2020-10-25",20,[1158],"Dystrophy, Retinal",[1138],{"trials":1161,"activeCount":99},[],{"intervention":1163,"totalTrials":333,"cells":1164},"Cabergoline",{"EARLY_PHASE1":1165,"PHASE1":1167,"PHASE2":1169,"PHASE3":1171,"PHASE4":1191,"NA":1193},{"trials":1166,"activeCount":99},[],{"trials":1168,"activeCount":99},[],{"trials":1170,"activeCount":99},[],{"trials":1172,"activeCount":99},[1173,1182],{"nctId":1174,"briefTitle":1175,"status":134,"phases":1176,"primaryCompletion":1177,"completion":1177,"start":1178,"enrollment":448,"conditions":1179,"interventions":1180},"NCT02271360","Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome",[89,90],"2015-12","2014-04",[15],[1181,1163],"Calcium Dobesilate",{"nctId":1183,"briefTitle":1184,"status":134,"phases":1185,"primaryCompletion":1186,"completion":1187,"start":1178,"enrollment":448,"conditions":1188,"interventions":1189},"NCT02134249","Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome",[89,90],"2015-09","2015-10",[15],[1190,1163],"Diosmin",{"trials":1192,"activeCount":99},[],{"trials":1194,"activeCount":99},[],{"intervention":1196,"totalTrials":333,"cells":1197},"clomiphene citrate",{"EARLY_PHASE1":1198,"PHASE1":1200,"PHASE2":1202,"PHASE3":1204,"PHASE4":1226,"NA":1228},{"trials":1199,"activeCount":99},[],{"trials":1201,"activeCount":99},[],{"trials":1203,"activeCount":99},[],{"trials":1205,"activeCount":99},[1206,1218],{"nctId":1207,"briefTitle":1208,"status":134,"phases":1209,"primaryCompletion":1210,"completion":1211,"start":1212,"enrollment":326,"conditions":1213,"interventions":1215},"NCT03770026","Autologous Platelet-rich Plasma for Clomiphene Citrate-induced Thin Endometrium",[89,90],"2019-01-01","2020-01-01","2018-01-01",[1214],"Infertility, Female, Associated With Anovulation",[1196,1216,1217],"Saline cervical flushing","Intrauterine Autologous platelet-rich plasma",{"nctId":1219,"briefTitle":1220,"status":134,"phases":1221,"primaryCompletion":1222,"completion":1222,"start":1223,"enrollment":290,"conditions":1224,"interventions":1225},"NCT02381184","Extended Clomiphene Citrate Regimen in Women With Polycystic Ovary Syndrome",[89,90],"2016-07","2014-06",[15],[1196],{"trials":1227,"activeCount":99},[],{"trials":1229,"activeCount":99},[],{"intervention":1231,"totalTrials":117,"cells":1232},"Mosapride",{"EARLY_PHASE1":1233,"PHASE1":1235,"PHASE2":1237,"PHASE3":1239,"PHASE4":1252,"NA":1254},{"trials":1234,"activeCount":99},[],{"trials":1236,"activeCount":99},[],{"trials":1238,"activeCount":99},[],{"trials":1240,"activeCount":99},[1241],{"nctId":1242,"briefTitle":1243,"status":134,"phases":1244,"primaryCompletion":1245,"completion":1246,"start":1247,"enrollment":1248,"conditions":1249,"interventions":1251},"NCT03477266","Mouth Dissolving Mosapride Tables Enhance Post Cesarean Gut Recovery",[90],"2018-06-01","2018-08-01","2018-04-01",400,[1250],"Prevention of Postoperative Ileus",[1231],{"trials":1253,"activeCount":99},[],{"trials":1255,"activeCount":99},[],{"intervention":425,"totalTrials":117,"cells":1257},{"EARLY_PHASE1":1258,"PHASE1":1260,"PHASE2":1262,"PHASE3":1264,"PHASE4":1270,"NA":1272},{"trials":1259,"activeCount":99},[],{"trials":1261,"activeCount":99},[],{"trials":1263,"activeCount":99},[],{"trials":1265,"activeCount":99},[1266],{"nctId":419,"briefTitle":420,"status":134,"phases":1267,"primaryCompletion":255,"completion":255,"start":422,"enrollment":215,"conditions":1268,"interventions":1269},[90],[28],[425,158],{"trials":1271,"activeCount":99},[],{"trials":1273,"activeCount":99},[],{"intervention":1275,"totalTrials":117,"cells":1276},"Sofosbuvir +daclatasvir+ simeprevir+Ribavirin",{"EARLY_PHASE1":1277,"PHASE1":1279,"PHASE2":1281,"PHASE3":1283,"PHASE4":1295,"NA":1297},{"trials":1278,"activeCount":99},[],{"trials":1280,"activeCount":99},[],{"trials":1282,"activeCount":99},[],{"trials":1284,"activeCount":99},[1285],{"nctId":1286,"briefTitle":1287,"status":134,"phases":1288,"primaryCompletion":1289,"completion":1290,"start":498,"enrollment":448,"conditions":1291,"interventions":1294},"NCT05616598","Effect of New Oral Treatment for Hepatitis C Virus on Seminal Parameters",[89,90],"2022-11-25","2022-12-31",[1292,1293],"Male Infertility","HCV",[1275],{"trials":1296,"activeCount":99},[],{"trials":1298,"activeCount":99},[],{"intervention":1181,"totalTrials":117,"cells":1300},{"EARLY_PHASE1":1301,"PHASE1":1303,"PHASE2":1305,"PHASE3":1307,"PHASE4":1313,"NA":1315},{"trials":1302,"activeCount":99},[],{"trials":1304,"activeCount":99},[],{"trials":1306,"activeCount":99},[],{"trials":1308,"activeCount":99},[1309],{"nctId":1174,"briefTitle":1175,"status":134,"phases":1310,"primaryCompletion":1177,"completion":1177,"start":1178,"enrollment":448,"conditions":1311,"interventions":1312},[89,90],[15],[1181,1163],{"trials":1314,"activeCount":99},[],{"trials":1316,"activeCount":99},[],{"intervention":1318,"totalTrials":117,"cells":1319},"IV Magnesium Sulfate",{"EARLY_PHASE1":1320,"PHASE1":1322,"PHASE2":1324,"PHASE3":1326,"PHASE4":1338,"NA":1340},{"trials":1321,"activeCount":99},[],{"trials":1323,"activeCount":99},[],{"trials":1325,"activeCount":99},[],{"trials":1327,"activeCount":99},[1328],{"nctId":1329,"briefTitle":1330,"status":134,"phases":1331,"primaryCompletion":1332,"completion":1332,"start":1333,"enrollment":242,"conditions":1334,"interventions":1336},"NCT06603766","Treatment of Persistent Pulmonary Hypertension in Neonates With Nebulized Magnesium Sulfate",[89,90],"2023-09-28","2021-10-01",[1335],"Magnesium Sulfate - PPHN",[1318,1337],"Inhalational magnesium sulfate",{"trials":1339,"activeCount":99},[],{"trials":1341,"activeCount":99},[],{"intervention":1337,"totalTrials":117,"cells":1343},{"EARLY_PHASE1":1344,"PHASE1":1346,"PHASE2":1348,"PHASE3":1350,"PHASE4":1356,"NA":1358},{"trials":1345,"activeCount":99},[],{"trials":1347,"activeCount":99},[],{"trials":1349,"activeCount":99},[],{"trials":1351,"activeCount":99},[1352],{"nctId":1329,"briefTitle":1330,"status":134,"phases":1353,"primaryCompletion":1332,"completion":1332,"start":1333,"enrollment":242,"conditions":1354,"interventions":1355},[89,90],[1335],[1318,1337],{"trials":1357,"activeCount":99},[],{"trials":1359,"activeCount":99},[],{"intervention":1361,"totalTrials":117,"cells":1362},"home made vitrification & thawing kit",{"EARLY_PHASE1":1363,"PHASE1":1365,"PHASE2":1367,"PHASE3":1369,"PHASE4":1383,"NA":1385},{"trials":1364,"activeCount":99},[],{"trials":1366,"activeCount":99},[],{"trials":1368,"activeCount":99},[],{"trials":1370,"activeCount":99},[1371],{"nctId":1372,"briefTitle":1373,"status":134,"phases":1374,"primaryCompletion":1375,"completion":1376,"start":1377,"enrollment":1378,"conditions":1379,"interventions":1381},"NCT03660904","A Comparison Between Home-made Vitrification & Thawing Media and a Commercially Available Brand on Blastocyst",[89,90],"2017-10-01","2018-06-15","2015-10-01",74,[1380],"Blastocyst Disintegration",[1361,1382],"commercially made vitrification & thawing kit",{"trials":1384,"activeCount":99},[],{"trials":1386,"activeCount":99},[],{"intervention":1382,"totalTrials":117,"cells":1388},{"EARLY_PHASE1":1389,"PHASE1":1391,"PHASE2":1393,"PHASE3":1395,"PHASE4":1401,"NA":1403},{"trials":1390,"activeCount":99},[],{"trials":1392,"activeCount":99},[],{"trials":1394,"activeCount":99},[],{"trials":1396,"activeCount":99},[1397],{"nctId":1372,"briefTitle":1373,"status":134,"phases":1398,"primaryCompletion":1375,"completion":1376,"start":1377,"enrollment":1378,"conditions":1399,"interventions":1400},[89,90],[1380],[1361,1382],{"trials":1402,"activeCount":99},[],{"trials":1404,"activeCount":99},[],{"intervention":1406,"totalTrials":117,"cells":1407},"Heparin",{"EARLY_PHASE1":1408,"PHASE1":1410,"PHASE2":1412,"PHASE3":1414,"PHASE4":1426,"NA":1428},{"trials":1409,"activeCount":99},[],{"trials":1411,"activeCount":99},[],{"trials":1413,"activeCount":99},[],{"trials":1415,"activeCount":99},[1416],{"nctId":1417,"briefTitle":1418,"status":278,"phases":1419,"primaryCompletion":1420,"completion":1421,"start":1422,"enrollment":448,"conditions":1423,"interventions":1425},"NCT02144064","Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated Heparin",[90],"2022-10","2022-12","2019-06-23",[1424],"Recurrent Pregnancy Loss",[1406],{"trials":1427,"activeCount":99},[],{"trials":1429,"activeCount":99},[],{"intervention":1431,"totalTrials":117,"cells":1432},"Intravenous normal saline",{"EARLY_PHASE1":1433,"PHASE1":1435,"PHASE2":1437,"PHASE3":1439,"PHASE4":1453,"NA":1455},{"trials":1434,"activeCount":99},[],{"trials":1436,"activeCount":99},[],{"trials":1438,"activeCount":99},[],{"trials":1440,"activeCount":99},[1441],{"nctId":1442,"briefTitle":1443,"status":134,"phases":1444,"primaryCompletion":1177,"completion":1177,"start":1445,"enrollment":1446,"conditions":1447,"interventions":1449},"NCT02707081","Efficacy of Intraperitoneal Versus Intravenous Lidocaine for Postcesarean Pain Relief",[89,90],"2013-06",150,[1448],"Postcesarean Pain Relief",[1431,1450,1451,1452],"Intraperitoneal normal saline","Intraperitoneal Lidocaine","Intravenous Lidocaine",{"trials":1454,"activeCount":99},[],{"trials":1456,"activeCount":99},[],{"intervention":1450,"totalTrials":117,"cells":1458},{"EARLY_PHASE1":1459,"PHASE1":1461,"PHASE2":1463,"PHASE3":1465,"PHASE4":1471,"NA":1473},{"trials":1460,"activeCount":99},[],{"trials":1462,"activeCount":99},[],{"trials":1464,"activeCount":99},[],{"trials":1466,"activeCount":99},[1467],{"nctId":1442,"briefTitle":1443,"status":134,"phases":1468,"primaryCompletion":1177,"completion":1177,"start":1445,"enrollment":1446,"conditions":1469,"interventions":1470},[89,90],[1448],[1431,1450,1451,1452],{"trials":1472,"activeCount":99},[],{"trials":1474,"activeCount":99},[],{"intervention":1451,"totalTrials":117,"cells":1476},{"EARLY_PHASE1":1477,"PHASE1":1479,"PHASE2":1481,"PHASE3":1483,"PHASE4":1489,"NA":1491},{"trials":1478,"activeCount":99},[],{"trials":1480,"activeCount":99},[],{"trials":1482,"activeCount":99},[],{"trials":1484,"activeCount":99},[1485],{"nctId":1442,"briefTitle":1443,"status":134,"phases":1486,"primaryCompletion":1177,"completion":1177,"start":1445,"enrollment":1446,"conditions":1487,"interventions":1488},[89,90],[1448],[1431,1450,1451,1452],{"trials":1490,"activeCount":99},[],{"trials":1492,"activeCount":99},[],{"intervention":1452,"totalTrials":117,"cells":1494},{"EARLY_PHASE1":1495,"PHASE1":1497,"PHASE2":1499,"PHASE3":1501,"PHASE4":1507,"NA":1509},{"trials":1496,"activeCount":99},[],{"trials":1498,"activeCount":99},[],{"trials":1500,"activeCount":99},[],{"trials":1502,"activeCount":99},[1503],{"nctId":1442,"briefTitle":1443,"status":134,"phases":1504,"primaryCompletion":1177,"completion":1177,"start":1445,"enrollment":1446,"conditions":1505,"interventions":1506},[89,90],[1448],[1431,1450,1451,1452],{"trials":1508,"activeCount":99},[],{"trials":1510,"activeCount":99},[],{"intervention":1512,"totalTrials":117,"cells":1513},"sildosin 4mg",{"EARLY_PHASE1":1514,"PHASE1":1516,"PHASE2":1518,"PHASE3":1520,"PHASE4":1532,"NA":1534},{"trials":1515,"activeCount":99},[],{"trials":1517,"activeCount":99},[],{"trials":1519,"activeCount":99},[],{"trials":1521,"activeCount":99},[1522],{"nctId":1523,"briefTitle":1524,"status":134,"phases":1525,"primaryCompletion":1526,"completion":838,"start":1526,"enrollment":1527,"conditions":1528,"interventions":1530},"NCT07081659","On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature Ejaculation",[89,90],"2024-03-01",95,[1529],"Premature (Early) Ejaculation",[1512,1531],"dapoxetine 60mg",{"trials":1533,"activeCount":99},[],{"trials":1535,"activeCount":99},[],{"intervention":1531,"totalTrials":117,"cells":1537},{"EARLY_PHASE1":1538,"PHASE1":1540,"PHASE2":1542,"PHASE3":1544,"PHASE4":1550,"NA":1552},{"trials":1539,"activeCount":99},[],{"trials":1541,"activeCount":99},[],{"trials":1543,"activeCount":99},[],{"trials":1545,"activeCount":99},[1546],{"nctId":1523,"briefTitle":1524,"status":134,"phases":1547,"primaryCompletion":1526,"completion":838,"start":1526,"enrollment":1527,"conditions":1548,"interventions":1549},[89,90],[1529],[1512,1531],{"trials":1551,"activeCount":99},[],{"trials":1553,"activeCount":99},[],{"intervention":1555,"totalTrials":117,"cells":1556},"Cetrorelix",{"EARLY_PHASE1":1557,"PHASE1":1559,"PHASE2":1561,"PHASE3":1563,"PHASE4":1574,"NA":1576},{"trials":1558,"activeCount":99},[],{"trials":1560,"activeCount":99},[],{"trials":1562,"activeCount":99},[],{"trials":1564,"activeCount":99},[1565],{"nctId":1566,"briefTitle":1567,"status":278,"phases":1568,"primaryCompletion":1569,"completion":1570,"start":1571,"enrollment":727,"conditions":1572,"interventions":1573},"NCT02823080","Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome",[89,90],"2017-04","2017-05","2014-10",[15],[1555],{"trials":1575,"activeCount":99},[],{"trials":1577,"activeCount":99},[],{"intervention":1579,"totalTrials":117,"cells":1580},"Oral Cabergoline",{"EARLY_PHASE1":1581,"PHASE1":1583,"PHASE2":1585,"PHASE3":1587,"PHASE4":1600,"NA":1602},{"trials":1582,"activeCount":99},[],{"trials":1584,"activeCount":99},[],{"trials":1586,"activeCount":99},[],{"trials":1588,"activeCount":99},[1589],{"nctId":1590,"briefTitle":1591,"status":134,"phases":1592,"primaryCompletion":1593,"completion":1593,"start":1594,"enrollment":1595,"conditions":1596,"interventions":1598},"NCT03473613","Cabergoline Versus Calcium Infusion in Ovarian Hyperstimulation Syndrome Prevention",[90],"2017-04-15","2014-10-01",230,[1597],"Ovarian Hyperstimulation",[1579,1599],"Calcium Gluconate",{"trials":1601,"activeCount":99},[],{"trials":1603,"activeCount":99},[],{"intervention":1599,"totalTrials":117,"cells":1605},{"EARLY_PHASE1":1606,"PHASE1":1608,"PHASE2":1610,"PHASE3":1612,"PHASE4":1618,"NA":1620},{"trials":1607,"activeCount":99},[],{"trials":1609,"activeCount":99},[],{"trials":1611,"activeCount":99},[],{"trials":1613,"activeCount":99},[1614],{"nctId":1590,"briefTitle":1591,"status":134,"phases":1615,"primaryCompletion":1593,"completion":1593,"start":1594,"enrollment":1595,"conditions":1616,"interventions":1617},[90],[1597],[1579,1599],{"trials":1619,"activeCount":99},[],{"trials":1621,"activeCount":99},[],{"intervention":1190,"totalTrials":117,"cells":1623},{"EARLY_PHASE1":1624,"PHASE1":1626,"PHASE2":1628,"PHASE3":1630,"PHASE4":1636,"NA":1638},{"trials":1625,"activeCount":99},[],{"trials":1627,"activeCount":99},[],{"trials":1629,"activeCount":99},[],{"trials":1631,"activeCount":99},[1632],{"nctId":1183,"briefTitle":1184,"status":134,"phases":1633,"primaryCompletion":1186,"completion":1187,"start":1178,"enrollment":448,"conditions":1634,"interventions":1635},[89,90],[15],[1190,1163],{"trials":1637,"activeCount":99},[],{"trials":1639,"activeCount":99},[],{"intervention":1641,"totalTrials":117,"cells":1642},"Human chorionic gonadotropin",{"EARLY_PHASE1":1643,"PHASE1":1645,"PHASE2":1647,"PHASE3":1649,"PHASE4":1662,"NA":1664},{"trials":1644,"activeCount":99},[],{"trials":1646,"activeCount":99},[],{"trials":1648,"activeCount":99},[],{"trials":1650,"activeCount":99},[1651],{"nctId":1652,"briefTitle":1653,"status":134,"phases":1654,"primaryCompletion":1655,"completion":1655,"start":1223,"enrollment":1656,"conditions":1657,"interventions":1659},"NCT02739516","Dual FSH\u002FHCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility",[90],"2015-08",108,[1658],"Unexplained Infertility",[1641,1660,1661],"FSH co-trigger","Letrozole",{"trials":1663,"activeCount":99},[],{"trials":1665,"activeCount":99},[],{"intervention":1660,"totalTrials":117,"cells":1667},{"EARLY_PHASE1":1668,"PHASE1":1670,"PHASE2":1672,"PHASE3":1674,"PHASE4":1680,"NA":1682},{"trials":1669,"activeCount":99},[],{"trials":1671,"activeCount":99},[],{"trials":1673,"activeCount":99},[],{"trials":1675,"activeCount":99},[1676],{"nctId":1652,"briefTitle":1653,"status":134,"phases":1677,"primaryCompletion":1655,"completion":1655,"start":1223,"enrollment":1656,"conditions":1678,"interventions":1679},[90],[1658],[1641,1660,1661],{"trials":1681,"activeCount":99},[],{"trials":1683,"activeCount":99},[],{"intervention":1685,"totalTrials":117,"cells":1686},"BTX A Topical",{"EARLY_PHASE1":1687,"PHASE1":1689,"PHASE2":1691,"PHASE3":1693,"PHASE4":1705,"NA":1707},{"trials":1688,"activeCount":99},[],{"trials":1690,"activeCount":99},[],{"trials":1692,"activeCount":99},[],{"trials":1694,"activeCount":99},[1695],{"nctId":1696,"briefTitle":1697,"status":134,"phases":1698,"primaryCompletion":1130,"completion":1699,"start":1700,"enrollment":326,"conditions":1701,"interventions":1703},"NCT04572516","Botulium Toxin Type A In Non Infectious Chronic Rhinosinusitis",[90],"2021-07-15","2020-05-01",[1702],"Chronic Rhinosinusitis (Diagnosis)",[1685,1704],"BTX A",{"trials":1706,"activeCount":99},[],{"trials":1708,"activeCount":99},[],{"intervention":1704,"totalTrials":117,"cells":1710},{"EARLY_PHASE1":1711,"PHASE1":1713,"PHASE2":1715,"PHASE3":1717,"PHASE4":1723,"NA":1725},{"trials":1712,"activeCount":99},[],{"trials":1714,"activeCount":99},[],{"trials":1716,"activeCount":99},[],{"trials":1718,"activeCount":99},[1719],{"nctId":1696,"briefTitle":1697,"status":134,"phases":1720,"primaryCompletion":1130,"completion":1699,"start":1700,"enrollment":326,"conditions":1721,"interventions":1722},[90],[1702],[1685,1704],{"trials":1724,"activeCount":99},[],{"trials":1726,"activeCount":99},[],{"intervention":1728,"totalTrials":117,"cells":1729},"Suprachoroidal Triamcinolone acetonide injection for serous retinal detachment in VKH disease",{"EARLY_PHASE1":1730,"PHASE1":1732,"PHASE2":1734,"PHASE3":1736,"PHASE4":1749,"NA":1751},{"trials":1731,"activeCount":99},[],{"trials":1733,"activeCount":99},[],{"trials":1735,"activeCount":99},[],{"trials":1737,"activeCount":99},[1738],{"nctId":1739,"briefTitle":1740,"status":134,"phases":1741,"primaryCompletion":1742,"completion":1743,"start":1744,"enrollment":1745,"conditions":1746,"interventions":1748},"NCT05031143","Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment",[89,90],"2021-02-20","2021-08-24","2020-04-01",6,[1747],"Vogt Koyanagi Harada Disease",[1728],{"trials":1750,"activeCount":99},[],{"trials":1752,"activeCount":99},[],{"intervention":1754,"totalTrials":117,"cells":1755},"mometasone furoate nasal spray",{"EARLY_PHASE1":1756,"PHASE1":1758,"PHASE2":1760,"PHASE3":1762,"PHASE4":1774,"NA":1776},{"trials":1757,"activeCount":99},[],{"trials":1759,"activeCount":99},[],{"trials":1761,"activeCount":99},[],{"trials":1763,"activeCount":99},[1764],{"nctId":1765,"briefTitle":1766,"status":134,"phases":1767,"primaryCompletion":1155,"completion":1768,"start":1769,"enrollment":154,"conditions":1770,"interventions":1773},"NCT04484493","Corticosteroid Nasal Spray in COVID-19 Anosmia",[90],"2020-11-03","2020-08-08",[1771,1772],"Covid19","Anosmia",[1754],{"trials":1775,"activeCount":99},[],{"trials":1777,"activeCount":99},[],{"intervention":1779,"totalTrials":117,"cells":1780},"BEOVU intravitreal",{"EARLY_PHASE1":1781,"PHASE1":1783,"PHASE2":1785,"PHASE3":1787,"PHASE4":1799,"NA":1801},{"trials":1782,"activeCount":99},[],{"trials":1784,"activeCount":99},[],{"trials":1786,"activeCount":99},[],{"trials":1788,"activeCount":99},[1789],{"nctId":1790,"briefTitle":1791,"status":278,"phases":1792,"primaryCompletion":1793,"completion":1794,"start":1795,"enrollment":215,"conditions":1796,"interventions":1798},"NCT04955171","BEOVU Versus Eylea in the Treatment of Diabetic Macular Edema",[90],"2022-03","2022-04","2021-01-12",[1797],"Macular Edema",[1779],{"trials":1800,"activeCount":99},[],{"trials":1802,"activeCount":99},[],{"intervention":1804,"totalTrials":117,"cells":1805},"OnabotulinumtoxinA",{"EARLY_PHASE1":1806,"PHASE1":1808,"PHASE2":1810,"PHASE3":1812,"PHASE4":1826,"NA":1828},{"trials":1807,"activeCount":99},[],{"trials":1809,"activeCount":99},[],{"trials":1811,"activeCount":99},[],{"trials":1813,"activeCount":99},[1814],{"nctId":1815,"briefTitle":1816,"status":278,"phases":1817,"primaryCompletion":1818,"completion":1819,"start":1820,"enrollment":1821,"conditions":1822,"interventions":1824},"NCT04172558","Intracavernous Injection of Botox 100 U for Treatment of PDE5Is Inconvenient Patients With ED",[89,90],"2022-10-01","2022-11-01","2019-03-10",124,[1823],"Erectile Dysfunction",[1804,1825],"Trimix",{"trials":1827,"activeCount":99},[],{"trials":1829,"activeCount":99},[],{"intervention":1825,"totalTrials":117,"cells":1831},{"EARLY_PHASE1":1832,"PHASE1":1834,"PHASE2":1836,"PHASE3":1838,"PHASE4":1844,"NA":1846},{"trials":1833,"activeCount":99},[],{"trials":1835,"activeCount":99},[],{"trials":1837,"activeCount":99},[],{"trials":1839,"activeCount":99},[1840],{"nctId":1815,"briefTitle":1816,"status":278,"phases":1841,"primaryCompletion":1818,"completion":1819,"start":1820,"enrollment":1821,"conditions":1842,"interventions":1843},[89,90],[1823],[1804,1825],{"trials":1845,"activeCount":99},[],{"trials":1847,"activeCount":99},[],{"intervention":1849,"totalTrials":117,"cells":1850},"combined oral contraceptive pills",{"EARLY_PHASE1":1851,"PHASE1":1853,"PHASE2":1855,"PHASE3":1857,"PHASE4":1870,"NA":1872},{"trials":1852,"activeCount":99},[],{"trials":1854,"activeCount":99},[],{"trials":1856,"activeCount":99},[],{"trials":1858,"activeCount":99},[1859],{"nctId":1860,"briefTitle":1861,"status":278,"phases":1862,"primaryCompletion":1863,"completion":1864,"start":1865,"enrollment":1866,"conditions":1867,"interventions":1869},"NCT03357640","Are the Combined Oral Contraceptive Pills Needed for Management of the Simple Ovarian Cysts in Reproductive Women?",[89,90],"2018-05","2018-06","2017-05-01",118,[1868],"Ovary Cyst",[1849],{"trials":1871,"activeCount":99},[],{"trials":1873,"activeCount":99},[],{"intervention":1216,"totalTrials":117,"cells":1875},{"EARLY_PHASE1":1876,"PHASE1":1878,"PHASE2":1880,"PHASE3":1882,"PHASE4":1888,"NA":1890},{"trials":1877,"activeCount":99},[],{"trials":1879,"activeCount":99},[],{"trials":1881,"activeCount":99},[],{"trials":1883,"activeCount":99},[1884],{"nctId":1207,"briefTitle":1208,"status":134,"phases":1885,"primaryCompletion":1210,"completion":1211,"start":1212,"enrollment":326,"conditions":1886,"interventions":1887},[89,90],[1214],[1196,1216,1217],{"trials":1889,"activeCount":99},[],{"trials":1891,"activeCount":99},[],{"intervention":1217,"totalTrials":117,"cells":1893},{"EARLY_PHASE1":1894,"PHASE1":1896,"PHASE2":1898,"PHASE3":1900,"PHASE4":1906,"NA":1908},{"trials":1895,"activeCount":99},[],{"trials":1897,"activeCount":99},[],{"trials":1899,"activeCount":99},[],{"trials":1901,"activeCount":99},[1902],{"nctId":1207,"briefTitle":1208,"status":134,"phases":1903,"primaryCompletion":1210,"completion":1211,"start":1212,"enrollment":326,"conditions":1904,"interventions":1905},[89,90],[1214],[1196,1216,1217],{"trials":1907,"activeCount":99},[],{"trials":1909,"activeCount":99},[],{"intervention":1911,"totalTrials":117,"cells":1912},"isosorbide mononitrate",{"EARLY_PHASE1":1913,"PHASE1":1915,"PHASE2":1917,"PHASE3":1919,"PHASE4":1930,"NA":1932},{"trials":1914,"activeCount":99},[],{"trials":1916,"activeCount":99},[],{"trials":1918,"activeCount":99},[],{"trials":1920,"activeCount":99},[1921],{"nctId":1922,"briefTitle":1923,"status":134,"phases":1924,"primaryCompletion":1925,"completion":1655,"start":1926,"enrollment":154,"conditions":1927,"interventions":1929},"NCT02712125","Nitric Oxide Donors for Treatment of Isolated Oligohydramnios",[89,90],"2015-06","2013-08",[1928],"Isolated (Idiopathic) Oligohydramnios",[1911],{"trials":1931,"activeCount":99},[],{"trials":1933,"activeCount":99},[],{"intervention":1935,"totalTrials":117,"cells":1936},"Triptorelin SR",{"EARLY_PHASE1":1937,"PHASE1":1939,"PHASE2":1941,"PHASE3":1943,"PHASE4":1954,"NA":1956},{"trials":1938,"activeCount":99},[],{"trials":1940,"activeCount":99},[],{"trials":1942,"activeCount":99},[],{"trials":1944,"activeCount":99},[1945],{"nctId":1946,"briefTitle":1947,"status":278,"phases":1948,"primaryCompletion":1864,"completion":1949,"start":1950,"enrollment":448,"conditions":1951,"interventions":1953},"NCT03353883","Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?",[89,90],"2018-08","2017-06-01",[1952],"Infertility, Female",[1935],{"trials":1955,"activeCount":99},[],{"trials":1957,"activeCount":99},[],{"intervention":192,"totalTrials":333,"cells":1959},{"EARLY_PHASE1":1960,"PHASE1":1962,"PHASE2":1964,"PHASE3":1974,"PHASE4":1976,"NA":1978},{"trials":1961,"activeCount":99},[],{"trials":1963,"activeCount":99},[],{"trials":1965,"activeCount":99},[1966,1970],{"nctId":495,"briefTitle":496,"status":134,"phases":1967,"primaryCompletion":498,"completion":499,"start":500,"enrollment":125,"conditions":1968,"interventions":1969},[89],[502],[192,85,504],{"nctId":182,"briefTitle":183,"status":134,"phases":1971,"primaryCompletion":185,"completion":186,"start":187,"enrollment":188,"conditions":1972,"interventions":1973},[89],[190],[172,192],{"trials":1975,"activeCount":99},[],{"trials":1977,"activeCount":99},[],{"trials":1979,"activeCount":99},[],{"intervention":1981,"totalTrials":117,"cells":1982},"Salicylic Acid\u002FLactic Acid Topical Solution",{"EARLY_PHASE1":1983,"PHASE1":1985,"PHASE2":1987,"PHASE3":2001,"PHASE4":2003,"NA":2005},{"trials":1984,"activeCount":99},[],{"trials":1986,"activeCount":99},[],{"trials":1988,"activeCount":99},[1989],{"nctId":1990,"briefTitle":1991,"status":134,"phases":1992,"primaryCompletion":212,"completion":301,"start":1993,"enrollment":1994,"conditions":1995,"interventions":1998},"NCT07329907","Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic",[89],"2023-12-01",126,[1996,1997],"Warts","Human Papilloma Virus (HPV)",[1981,1999,2000],"Candida Antigen Intralesional","Candida Antigen and Salicylic Acid\u002FLactic Acid",{"trials":2002,"activeCount":99},[],{"trials":2004,"activeCount":99},[],{"trials":2006,"activeCount":99},[],{"intervention":1999,"totalTrials":117,"cells":2008},{"EARLY_PHASE1":2009,"PHASE1":2011,"PHASE2":2013,"PHASE3":2019,"PHASE4":2021,"NA":2023},{"trials":2010,"activeCount":99},[],{"trials":2012,"activeCount":99},[],{"trials":2014,"activeCount":99},[2015],{"nctId":1990,"briefTitle":1991,"status":134,"phases":2016,"primaryCompletion":212,"completion":301,"start":1993,"enrollment":1994,"conditions":2017,"interventions":2018},[89],[1996,1997],[1981,1999,2000],{"trials":2020,"activeCount":99},[],{"trials":2022,"activeCount":99},[],{"trials":2024,"activeCount":99},[],{"intervention":2000,"totalTrials":117,"cells":2026},{"EARLY_PHASE1":2027,"PHASE1":2029,"PHASE2":2031,"PHASE3":2037,"PHASE4":2039,"NA":2041},{"trials":2028,"activeCount":99},[],{"trials":2030,"activeCount":99},[],{"trials":2032,"activeCount":99},[2033],{"nctId":1990,"briefTitle":1991,"status":134,"phases":2034,"primaryCompletion":212,"completion":301,"start":1993,"enrollment":1994,"conditions":2035,"interventions":2036},[89],[1996,1997],[1981,1999,2000],{"trials":2038,"activeCount":99},[],{"trials":2040,"activeCount":99},[],{"trials":2042,"activeCount":99},[],{"intervention":2044,"totalTrials":117,"cells":2045},"Tranexamic Acid 100 milligram\u002FMilliliter",{"EARLY_PHASE1":2046,"PHASE1":2048,"PHASE2":2050,"PHASE3":2062,"PHASE4":2064,"NA":2066},{"trials":2047,"activeCount":99},[],{"trials":2049,"activeCount":99},[],{"trials":2051,"activeCount":99},[2052],{"nctId":2053,"briefTitle":2054,"status":278,"phases":2055,"primaryCompletion":2056,"completion":2057,"start":1211,"enrollment":215,"conditions":2058,"interventions":2060},"NCT04707950","Tranexamic Acid for the Prevention of Postpartum Haemorrhage",[88,89],"2021-02-25","2021-03-30",[2059],"Postpartum Hemorrhage",[2044,2061],"Oxytocin",{"trials":2063,"activeCount":99},[],{"trials":2065,"activeCount":99},[],{"trials":2067,"activeCount":99},[],{"intervention":2061,"totalTrials":117,"cells":2069},{"EARLY_PHASE1":2070,"PHASE1":2072,"PHASE2":2074,"PHASE3":2080,"PHASE4":2082,"NA":2084},{"trials":2071,"activeCount":99},[],{"trials":2073,"activeCount":99},[],{"trials":2075,"activeCount":99},[2076],{"nctId":2053,"briefTitle":2054,"status":278,"phases":2077,"primaryCompletion":2056,"completion":2057,"start":1211,"enrollment":215,"conditions":2078,"interventions":2079},[88,89],[2059],[2044,2061],{"trials":2081,"activeCount":99},[],{"trials":2083,"activeCount":99},[],{"trials":2085,"activeCount":99},[],{"intervention":2087,"totalTrials":117,"cells":2088},"Intralesional combined furosemide",{"EARLY_PHASE1":2089,"PHASE1":2091,"PHASE2":2093,"PHASE3":2104,"PHASE4":2106,"NA":2108},{"trials":2090,"activeCount":99},[],{"trials":2092,"activeCount":99},[],{"trials":2094,"activeCount":99},[2095],{"nctId":2096,"briefTitle":2097,"status":134,"phases":2098,"primaryCompletion":924,"completion":2099,"start":651,"enrollment":345,"conditions":2100,"interventions":2102},"NCT07307131","Furosemide-Digoxin vs. Polidocanol for Cutaneous Warts",[89],"2025-09-30",[2101,1997],"Cutaneous Warts",[2087,2103],"Intralesional polidocanol 2%",{"trials":2105,"activeCount":99},[],{"trials":2107,"activeCount":99},[],{"trials":2109,"activeCount":99},[],{"intervention":2103,"totalTrials":117,"cells":2111},{"EARLY_PHASE1":2112,"PHASE1":2114,"PHASE2":2116,"PHASE3":2122,"PHASE4":2124,"NA":2126},{"trials":2113,"activeCount":99},[],{"trials":2115,"activeCount":99},[],{"trials":2117,"activeCount":99},[2118],{"nctId":2096,"briefTitle":2097,"status":134,"phases":2119,"primaryCompletion":924,"completion":2099,"start":651,"enrollment":345,"conditions":2120,"interventions":2121},[89],[2101,1997],[2087,2103],{"trials":2123,"activeCount":99},[],{"trials":2125,"activeCount":99},[],{"trials":2127,"activeCount":99},[],{"intervention":2129,"totalTrials":117,"cells":2130},"combination therapy for high peripheral NK cells",{"EARLY_PHASE1":2131,"PHASE1":2133,"PHASE2":2135,"PHASE3":2145,"PHASE4":2147,"NA":2149},{"trials":2132,"activeCount":99},[],{"trials":2134,"activeCount":99},[],{"trials":2136,"activeCount":99},[2137],{"nctId":2138,"briefTitle":2139,"status":134,"phases":2140,"primaryCompletion":2141,"completion":2142,"start":1210,"enrollment":154,"conditions":2143,"interventions":2144},"NCT03792997","A Therapeutic Protocol in Previous Failed ART Patients With High Total NK Cells",[89],"2019-12-15","2021-12-10",[1658],[2129],{"trials":2146,"activeCount":99},[],{"trials":2148,"activeCount":99},[],{"trials":2150,"activeCount":99},[],{"intervention":2152,"totalTrials":117,"cells":2153},"Vaginal Progesterone Therapy",{"EARLY_PHASE1":2154,"PHASE1":2156,"PHASE2":2158,"PHASE3":2171,"PHASE4":2173,"NA":2175},{"trials":2155,"activeCount":99},[],{"trials":2157,"activeCount":99},[],{"trials":2159,"activeCount":99},[2160],{"nctId":2161,"briefTitle":2162,"status":134,"phases":2163,"primaryCompletion":2164,"completion":2165,"start":2166,"enrollment":2167,"conditions":2168,"interventions":2170},"NCT07319715","Cerclage and Progesterone for Twin Pregnancies",[89],"2024-08-24","2025-06-14","2023-01-20",59,[2169],"Twin Pregnancy With Antenatal Problem",[2152],{"trials":2172,"activeCount":99},[],{"trials":2174,"activeCount":99},[],{"trials":2176,"activeCount":99},[],{"intervention":2178,"totalTrials":117,"cells":2179},"Botulinum toxin type A 50 units",{"EARLY_PHASE1":2180,"PHASE1":2182,"PHASE2":2184,"PHASE3":2197,"PHASE4":2199,"NA":2201},{"trials":2181,"activeCount":99},[],{"trials":2183,"activeCount":99},[],{"trials":2185,"activeCount":99},[2186],{"nctId":2187,"briefTitle":2188,"status":134,"phases":2189,"primaryCompletion":2190,"completion":2191,"start":2192,"enrollment":448,"conditions":2193,"interventions":2195},"NCT03355963","Intracavernosal Injection of Botulinum Toxin Type A (50 and 100 Unit) in the Treatment of Erectile Dysfunction",[89],"2019-01-25","2019-02-20","2016-07-12",[1823,2194],"Botulinum Toxin",[2178,2196],"Botulinum toxin type A 100 units",{"trials":2198,"activeCount":99},[],{"trials":2200,"activeCount":99},[],{"trials":2202,"activeCount":99},[],{"intervention":2196,"totalTrials":117,"cells":2204},{"EARLY_PHASE1":2205,"PHASE1":2207,"PHASE2":2209,"PHASE3":2215,"PHASE4":2217,"NA":2219},{"trials":2206,"activeCount":99},[],{"trials":2208,"activeCount":99},[],{"trials":2210,"activeCount":99},[2211],{"nctId":2187,"briefTitle":2188,"status":134,"phases":2212,"primaryCompletion":2190,"completion":2191,"start":2192,"enrollment":448,"conditions":2213,"interventions":2214},[89],[1823,2194],[2178,2196],{"trials":2216,"activeCount":99},[],{"trials":2218,"activeCount":99},[],{"trials":2220,"activeCount":99},[],{"intervention":964,"totalTrials":117,"cells":2222},{"EARLY_PHASE1":2223,"PHASE1":2225,"PHASE2":2227,"PHASE3":2233,"PHASE4":2235,"NA":2237},{"trials":2224,"activeCount":99},[],{"trials":2226,"activeCount":99},[],{"trials":2228,"activeCount":99},[2229],{"nctId":956,"briefTitle":957,"status":134,"phases":2230,"primaryCompletion":44,"completion":881,"start":959,"enrollment":960,"conditions":2231,"interventions":2232},[89],[962],[964,144],{"trials":2234,"activeCount":99},[],{"trials":2236,"activeCount":99},[],{"trials":2238,"activeCount":99},[],{"intervention":2240,"totalTrials":117,"cells":2241},"dydrgesterone 10 mg( tab)\u002F12hs\u002F14 days",{"EARLY_PHASE1":2242,"PHASE1":2244,"PHASE2":2246,"PHASE3":2259,"PHASE4":2261,"NA":2263},{"trials":2243,"activeCount":99},[],{"trials":2245,"activeCount":99},[],{"trials":2247,"activeCount":99},[2248],{"nctId":2249,"briefTitle":2250,"status":2251,"phases":2252,"primaryCompletion":2253,"completion":2253,"start":2254,"enrollment":1156,"conditions":2255,"interventions":2257},"NCT03794037","Montelukast for Prevention & Treatment of OHSS","SUSPENDED",[89],"2023-12","2018-12-05",[2256],"Ovarian Hyperstimulation Syndrome",[2240,2258],"montelukast 10 mg(tab) oral\u002F24hs\u002F 7 days dydrgesterone 10 mg( tab) oral\u002F12hs\u002F14 days",{"trials":2260,"activeCount":99},[],{"trials":2262,"activeCount":99},[],{"trials":2264,"activeCount":99},[],{"intervention":2258,"totalTrials":117,"cells":2266},{"EARLY_PHASE1":2267,"PHASE1":2269,"PHASE2":2271,"PHASE3":2277,"PHASE4":2279,"NA":2281},{"trials":2268,"activeCount":99},[],{"trials":2270,"activeCount":99},[],{"trials":2272,"activeCount":99},[2273],{"nctId":2249,"briefTitle":2250,"status":2251,"phases":2274,"primaryCompletion":2253,"completion":2253,"start":2254,"enrollment":1156,"conditions":2275,"interventions":2276},[89],[2256],[2240,2258],{"trials":2278,"activeCount":99},[],{"trials":2280,"activeCount":99},[],{"trials":2282,"activeCount":99},[],{"intervention":2284,"totalTrials":117,"cells":2285},"Chromax",{"EARLY_PHASE1":2286,"PHASE1":2288,"PHASE2":2290,"PHASE3":2303,"PHASE4":2305,"NA":2307},{"trials":2287,"activeCount":99},[],{"trials":2289,"activeCount":99},[],{"trials":2291,"activeCount":99},[2292],{"nctId":2293,"briefTitle":2294,"status":278,"phases":2295,"primaryCompletion":2296,"completion":2297,"start":2298,"enrollment":361,"conditions":2299,"interventions":2301},"NCT04590534","Evaluation of the Effect of Garcinia in Combination With Chromium on the Clinical Outcomes of Patients With LUTS\u002FBPH",[89],"2023-02-01","2023-03-12","2020-08-01",[2300],"Prostatic Hyperplasia",[2284,2302],"Sildosin Group",{"trials":2304,"activeCount":99},[],{"trials":2306,"activeCount":99},[],{"trials":2308,"activeCount":99},[],{"intervention":2310,"totalTrials":117,"cells":2311},"Epidural",{"EARLY_PHASE1":2312,"PHASE1":2314,"PHASE2":2316,"PHASE3":2329,"PHASE4":2331,"NA":2333},{"trials":2313,"activeCount":99},[],{"trials":2315,"activeCount":99},[],{"trials":2317,"activeCount":99},[2318],{"nctId":2319,"briefTitle":2320,"status":134,"phases":2321,"primaryCompletion":2322,"completion":2323,"start":2324,"enrollment":2325,"conditions":2326,"interventions":2328},"NCT07370233","Triple Therapy Strategy for Managing Persistent Pain After Spinal Microdiscectomy",[89],"2025-03-22","2025-09-23","2023-02-20",63,[2327],"Spinal Disk Injury",[2310],{"trials":2330,"activeCount":99},[],{"trials":2332,"activeCount":99},[],{"trials":2334,"activeCount":99},[],{"intervention":2336,"totalTrials":333,"cells":2337},"Insulin",{"EARLY_PHASE1":2338,"PHASE1":2340,"PHASE2":2365,"PHASE3":2367,"PHASE4":2369,"NA":2371},{"trials":2339,"activeCount":99},[],{"trials":2341,"activeCount":99},[2342,2352],{"nctId":2343,"briefTitle":2344,"status":134,"phases":2345,"primaryCompletion":2346,"completion":185,"start":1744,"enrollment":2347,"conditions":2348,"interventions":2350},"NCT05441631","Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients",[88],"2020-07-15",436,[26,2349],"Dysglycemia",[2336,2351],"Subcutaneous Insulin",{"nctId":2353,"briefTitle":2354,"status":278,"phases":2355,"primaryCompletion":2356,"completion":2357,"start":2358,"enrollment":2359,"conditions":2360,"interventions":2362},"NCT05331859","Topical Insulin Versus Autologous Serum After Corneal Surgeries",[88],"2022-08","2022-09","2022-05",250,[2361],"Corneal Epithelial Wound",[2336,2363,2364],"autologous serum","conventional",{"trials":2366,"activeCount":99},[],{"trials":2368,"activeCount":99},[],{"trials":2370,"activeCount":99},[],{"trials":2372,"activeCount":99},[],{"intervention":2351,"totalTrials":117,"cells":2374},{"EARLY_PHASE1":2375,"PHASE1":2377,"PHASE2":2383,"PHASE3":2385,"PHASE4":2387,"NA":2389},{"trials":2376,"activeCount":99},[],{"trials":2378,"activeCount":99},[2379],{"nctId":2343,"briefTitle":2344,"status":134,"phases":2380,"primaryCompletion":2346,"completion":185,"start":1744,"enrollment":2347,"conditions":2381,"interventions":2382},[88],[26,2349],[2336,2351],{"trials":2384,"activeCount":99},[],{"trials":2386,"activeCount":99},[],{"trials":2388,"activeCount":99},[],{"trials":2390,"activeCount":99},[],{"intervention":2363,"totalTrials":117,"cells":2392},{"EARLY_PHASE1":2393,"PHASE1":2395,"PHASE2":2401,"PHASE3":2403,"PHASE4":2405,"NA":2407},{"trials":2394,"activeCount":99},[],{"trials":2396,"activeCount":99},[2397],{"nctId":2353,"briefTitle":2354,"status":278,"phases":2398,"primaryCompletion":2356,"completion":2357,"start":2358,"enrollment":2359,"conditions":2399,"interventions":2400},[88],[2361],[2336,2363,2364],{"trials":2402,"activeCount":99},[],{"trials":2404,"activeCount":99},[],{"trials":2406,"activeCount":99},[],{"trials":2408,"activeCount":99},[],{"intervention":2364,"totalTrials":117,"cells":2410},{"EARLY_PHASE1":2411,"PHASE1":2413,"PHASE2":2419,"PHASE3":2421,"PHASE4":2423,"NA":2425},{"trials":2412,"activeCount":99},[],{"trials":2414,"activeCount":99},[2415],{"nctId":2353,"briefTitle":2354,"status":278,"phases":2416,"primaryCompletion":2356,"completion":2357,"start":2358,"enrollment":2359,"conditions":2417,"interventions":2418},[88],[2361],[2336,2363,2364],{"trials":2420,"activeCount":99},[],{"trials":2422,"activeCount":99},[],{"trials":2424,"activeCount":99},[],{"trials":2426,"activeCount":99},[],{"intervention":2428,"totalTrials":117,"cells":2429},"Corticosteroid",{"EARLY_PHASE1":2430,"PHASE1":2442,"PHASE2":2444,"PHASE3":2446,"PHASE4":2448,"NA":2450},{"trials":2431,"activeCount":99},[2432],{"nctId":2433,"briefTitle":2434,"status":278,"phases":2435,"primaryCompletion":2436,"completion":2253,"start":2437,"enrollment":154,"conditions":2438,"interventions":2441},"NCT05742061","Intra-articular Platelet Rich Plasma vs Corticosteroid in Treatment of Knee Osteoarthritis Patients",[87],"2023-10","2023-04",[2439,2428,2440],"Osteoarthritis Knee","Platelet Rich Plasma",[2428],{"trials":2443,"activeCount":99},[],{"trials":2445,"activeCount":99},[],{"trials":2447,"activeCount":99},[],{"trials":2449,"activeCount":99},[],{"trials":2451,"activeCount":99},[],{"intervention":545,"totalTrials":117,"cells":2453},{"EARLY_PHASE1":2454,"PHASE1":2460,"PHASE2":2462,"PHASE3":2464,"PHASE4":2466,"NA":2468},{"trials":2455,"activeCount":99},[2456],{"nctId":534,"briefTitle":535,"status":278,"phases":2457,"primaryCompletion":537,"completion":538,"start":539,"enrollment":540,"conditions":2458,"interventions":2459},[87],[542,543],[529,545],{"trials":2461,"activeCount":99},[],{"trials":2463,"activeCount":99},[],{"trials":2465,"activeCount":99},[],{"trials":2467,"activeCount":99},[],{"trials":2469,"activeCount":99},[],{"intervention":2471,"totalTrials":117,"cells":2472},"pentoxifylline",{"EARLY_PHASE1":2473,"PHASE1":2485,"PHASE2":2487,"PHASE3":2489,"PHASE4":2491,"NA":2493},{"trials":2474,"activeCount":99},[2475],{"nctId":2476,"briefTitle":2477,"status":278,"phases":2478,"primaryCompletion":2479,"completion":2479,"start":2480,"enrollment":2481,"conditions":2482,"interventions":2483},"NCT03476564","Effects of Pentoxifylline and Vitamin E on Pregnancy Rate in Infertile Women Treated by ICSI:",[87],"2018-09-01","2018-05-01",140,[1952],[2471,2484],"Vit E",{"trials":2486,"activeCount":99},[],{"trials":2488,"activeCount":99},[],{"trials":2490,"activeCount":99},[],{"trials":2492,"activeCount":99},[],{"trials":2494,"activeCount":99},[],{"intervention":2484,"totalTrials":117,"cells":2496},{"EARLY_PHASE1":2497,"PHASE1":2503,"PHASE2":2505,"PHASE3":2507,"PHASE4":2509,"NA":2511},{"trials":2498,"activeCount":99},[2499],{"nctId":2476,"briefTitle":2477,"status":278,"phases":2500,"primaryCompletion":2479,"completion":2479,"start":2480,"enrollment":2481,"conditions":2501,"interventions":2502},[87],[1952],[2471,2484],{"trials":2504,"activeCount":99},[],{"trials":2506,"activeCount":99},[],{"trials":2508,"activeCount":99},[],{"trials":2510,"activeCount":99},[],{"trials":2512,"activeCount":99},[],{"intervention":2514,"totalTrials":117,"cells":2515},"cyproterone acetate",{"EARLY_PHASE1":2516,"PHASE1":2530,"PHASE2":2532,"PHASE3":2534,"PHASE4":2536,"NA":2538},{"trials":2517,"activeCount":99},[2518],{"nctId":2519,"briefTitle":2520,"status":134,"phases":2521,"primaryCompletion":2522,"completion":2523,"start":2524,"enrollment":215,"conditions":2525,"interventions":2527},"NCT04848181","The Effect of Pre-operative Use of Finasteride Versus Cyproterone Acetate on Blood Loss With Transurethral Resection of Prostate",[87],"2020-07-01","2020-07-09","2019-07-01",[2526],"Prostate Hyperplasia",[2514,2528,2529],"finasteride","no treatment received",{"trials":2531,"activeCount":99},[],{"trials":2533,"activeCount":99},[],{"trials":2535,"activeCount":99},[],{"trials":2537,"activeCount":99},[],{"trials":2539,"activeCount":99},[],{"intervention":2528,"totalTrials":117,"cells":2541},{"EARLY_PHASE1":2542,"PHASE1":2548,"PHASE2":2550,"PHASE3":2552,"PHASE4":2554,"NA":2556},{"trials":2543,"activeCount":99},[2544],{"nctId":2519,"briefTitle":2520,"status":134,"phases":2545,"primaryCompletion":2522,"completion":2523,"start":2524,"enrollment":215,"conditions":2546,"interventions":2547},[87],[2526],[2514,2528,2529],{"trials":2549,"activeCount":99},[],{"trials":2551,"activeCount":99},[],{"trials":2553,"activeCount":99},[],{"trials":2555,"activeCount":99},[],{"trials":2557,"activeCount":99},[],{"intervention":2529,"totalTrials":117,"cells":2559},{"EARLY_PHASE1":2560,"PHASE1":2566,"PHASE2":2568,"PHASE3":2570,"PHASE4":2572,"NA":2574},{"trials":2561,"activeCount":99},[2562],{"nctId":2519,"briefTitle":2520,"status":134,"phases":2563,"primaryCompletion":2522,"completion":2523,"start":2524,"enrollment":215,"conditions":2564,"interventions":2565},[87],[2526],[2514,2528,2529],{"trials":2567,"activeCount":99},[],{"trials":2569,"activeCount":99},[],{"trials":2571,"activeCount":99},[],{"trials":2573,"activeCount":99},[],{"trials":2575,"activeCount":99},[],{"intervention":331,"totalTrials":29,"cells":2577},{"EARLY_PHASE1":2578,"PHASE1":2580,"PHASE2":2582,"PHASE3":2588,"PHASE4":2590,"NA":2608},{"trials":2579,"activeCount":99},[],{"trials":2581,"activeCount":99},[],{"trials":2583,"activeCount":99},[2584],{"nctId":495,"briefTitle":496,"status":134,"phases":2585,"primaryCompletion":498,"completion":499,"start":500,"enrollment":125,"conditions":2586,"interventions":2587},[89],[502],[192,85,504],{"trials":2589,"activeCount":99},[],{"trials":2591,"activeCount":99},[2592,2604],{"nctId":2593,"briefTitle":2594,"status":134,"phases":2595,"primaryCompletion":79,"completion":79,"start":2596,"enrollment":125,"conditions":2597,"interventions":2601},"NCT07582341","Combined Intravenous and Irrigation Tranexamic Acid During Percutaneous Nephrolithotomy",[91],"2025-05-30",[2598,2599,2600],"Kidney Stones","Surgical Blood Loss","Percutaneous Nephrolithotomy",[2602,2603],"Tranexamic acid","Normal Saline",{"nctId":1102,"briefTitle":1103,"status":134,"phases":2605,"primaryCompletion":44,"completion":1105,"start":1106,"enrollment":1107,"conditions":2606,"interventions":2607},[91],[1109],[504,1089],{"trials":2609,"activeCount":99},[2610,2620],{"nctId":2611,"briefTitle":2612,"status":134,"phases":2613,"primaryCompletion":2614,"completion":1993,"start":2615,"enrollment":154,"conditions":2616,"interventions":2618},"NCT06402019","Dexmedetomidine Infusion Impact on Chronic Pain Patients",[92],"2023-09-22","2023-03-01",[2617],"Chronic Pain",[2619,331],"Dexmedetomidine in 0.9 % NaCl 20 Mcg\u002F5 mL",{"nctId":320,"briefTitle":321,"status":134,"phases":2621,"primaryCompletion":323,"completion":324,"start":325,"enrollment":326,"conditions":2622,"interventions":2623},[92],[328],[172,330,331],{"intervention":2625,"totalTrials":333,"cells":2626},"Suprachoroidal triamcinolone acetonide (SCTA)",{"EARLY_PHASE1":2627,"PHASE1":2629,"PHASE2":2631,"PHASE3":2633,"PHASE4":2635,"NA":2637},{"trials":2628,"activeCount":99},[],{"trials":2630,"activeCount":99},[],{"trials":2632,"activeCount":99},[],{"trials":2634,"activeCount":99},[],{"trials":2636,"activeCount":99},[],{"trials":2638,"activeCount":99},[2639,2650],{"nctId":2640,"briefTitle":2641,"status":278,"phases":2642,"primaryCompletion":2643,"completion":2644,"start":2645,"enrollment":326,"conditions":2646,"interventions":2649},"NCT05288192","Changes After Suprachoroidal Injection.",[92],"2022-08-30","2022-09-01","2022-02-15",[2647,2648,33,1797],"Retina; Change","Intraocular Pressure",[2625],{"nctId":2651,"briefTitle":2652,"status":278,"phases":2653,"primaryCompletion":2654,"completion":1020,"start":2655,"enrollment":154,"conditions":2656,"interventions":2659},"NCT05496530","Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results)",[92],"2023-07-30","2022-07-10",[2657,1747,2658],"Diabetic Macular Edema","Retinal Vein Occlusion",[2660],"Suprachoroidal triamcinolone acetonide",{"intervention":160,"totalTrials":333,"cells":2662},{"EARLY_PHASE1":2663,"PHASE1":2665,"PHASE2":2667,"PHASE3":2669,"PHASE4":2671,"NA":2673},{"trials":2664,"activeCount":99},[],{"trials":2666,"activeCount":99},[],{"trials":2668,"activeCount":99},[],{"trials":2670,"activeCount":99},[],{"trials":2672,"activeCount":99},[],{"trials":2674,"activeCount":99},[2675,2685],{"nctId":2676,"briefTitle":2677,"status":134,"phases":2678,"primaryCompletion":2679,"completion":2680,"start":2681,"enrollment":361,"conditions":2682,"interventions":2684},"NCT05057767","Impact of Timing of Midazolam Administration on Incidence of Postoperative Nausea and Vomiting",[92],"2022-06-30","2022-07-31","2021-09-10",[2683],"Postoperative Nausea and Vomiting",[160],{"nctId":148,"briefTitle":149,"status":134,"phases":2686,"primaryCompletion":151,"completion":152,"start":153,"enrollment":154,"conditions":2687,"interventions":2688},[92],[156],[95,158,159,160],{"intervention":2690,"totalTrials":333,"cells":2691},"Silodosin",{"EARLY_PHASE1":2692,"PHASE1":2694,"PHASE2":2696,"PHASE3":2698,"PHASE4":2700,"NA":2702},{"trials":2693,"activeCount":99},[],{"trials":2695,"activeCount":99},[],{"trials":2697,"activeCount":99},[],{"trials":2699,"activeCount":99},[],{"trials":2701,"activeCount":99},[],{"trials":2703,"activeCount":99},[2704,2715],{"nctId":2705,"briefTitle":2706,"status":134,"phases":2707,"primaryCompletion":2708,"completion":2708,"start":2709,"enrollment":139,"conditions":2710,"interventions":2714},"NCT05823662","Double J Stenting and Sildosin After URSL for Lower Ureteric Stones",[92],"2023-03-02","2022-03-02",[2711,2712,2713],"Lower Ureteric Stones","Ureteroscopic Lithotripsy","DJ Stenting",[2690],{"nctId":2716,"briefTitle":2717,"status":134,"phases":2718,"primaryCompletion":2643,"completion":2643,"start":2719,"enrollment":2720,"conditions":2721,"interventions":2724},"NCT05789732","Silodosin, Tadalafil Alone vs. Silodosin Plus Tadalafil as MET for Lower Ureteric Stones",[92],"2022-03-30",168,[2711,2722,2723,2690],"Medical Expulsive Therapy","Tadalafil",[2690,2723,2725],"Silodosin and Tadalafil",{"intervention":2727,"totalTrials":333,"cells":2728},"Omega 3",{"EARLY_PHASE1":2729,"PHASE1":2731,"PHASE2":2733,"PHASE3":2735,"PHASE4":2737,"NA":2749},{"trials":2730,"activeCount":99},[],{"trials":2732,"activeCount":99},[],{"trials":2734,"activeCount":99},[],{"trials":2736,"activeCount":99},[],{"trials":2738,"activeCount":99},[2739],{"nctId":2740,"briefTitle":2741,"status":134,"phases":2742,"primaryCompletion":2743,"completion":2744,"start":2745,"enrollment":125,"conditions":2746,"interventions":2748},"NCT03686059","Outcome of Omega 3 FA and Punctal Plugs on Ocular Surface Disease",[91],"2019-11-15","2019-11-20","2018-07-02",[2747],"Ocular Surface Disease",[2727],{"trials":2750,"activeCount":99},[2751],{"nctId":2752,"briefTitle":2753,"status":134,"phases":2754,"primaryCompletion":651,"completion":651,"start":993,"enrollment":215,"conditions":2755,"interventions":2758},"NCT07138131","Impact of Omega 3 in Treatment of Inappropriate Sinus Tachycardia",[92],[2727,2756,2757],"Treatment","Inappropriate Sinus Tachycardia",[2727],{"intervention":1661,"totalTrials":333,"cells":2760},{"EARLY_PHASE1":2761,"PHASE1":2763,"PHASE2":2765,"PHASE3":2767,"PHASE4":2773,"NA":2775},{"trials":2762,"activeCount":99},[],{"trials":2764,"activeCount":99},[],{"trials":2766,"activeCount":99},[],{"trials":2768,"activeCount":99},[2769],{"nctId":1652,"briefTitle":1653,"status":134,"phases":2770,"primaryCompletion":1655,"completion":1655,"start":1223,"enrollment":1656,"conditions":2771,"interventions":2772},[90],[1658],[1641,1660,1661],{"trials":2774,"activeCount":99},[],{"trials":2776,"activeCount":99},[2777],{"nctId":2778,"briefTitle":2779,"status":134,"phases":2780,"primaryCompletion":2781,"completion":2782,"start":2783,"enrollment":125,"conditions":2784,"interventions":2786},"NCT03181919","Letrozole Step-up Protocol for Ovulation Induction in Infertile Women With PCOS",[92],"2017-01-01","2017-03-01","2016-01-01",[2785],"Infertility Poly Cystic Ovary",[1661],{"intervention":2788,"totalTrials":333,"cells":2789},"Rutin 500 MG Oral",{"EARLY_PHASE1":2790,"PHASE1":2792,"PHASE2":2794,"PHASE3":2806,"PHASE4":2808,"NA":2810},{"trials":2791,"activeCount":99},[],{"trials":2793,"activeCount":99},[],{"trials":2795,"activeCount":99},[2796],{"nctId":2797,"briefTitle":2798,"status":134,"phases":2799,"primaryCompletion":2800,"completion":2801,"start":2802,"enrollment":215,"conditions":2803,"interventions":2805},"NCT07370220","Effect of Rutin on Inflammation Pathways in Ulcerative Colitis Patients",[89],"2025-05-25","2025-11-15","2025-02-22",[2804],"Ulcerative Colitis",[2788],{"trials":2807,"activeCount":99},[],{"trials":2809,"activeCount":99},[],{"trials":2811,"activeCount":99},[2812],{"nctId":2813,"briefTitle":2814,"status":134,"phases":2815,"primaryCompletion":2816,"completion":2817,"start":2818,"enrollment":215,"conditions":2819,"interventions":2820},"NCT07147842","Rutin Therapy Role in Reducing Ulcerative Colitis Severity",[92],"2025-01-08","2025-05-20","2024-11-01",[2804],[2821],"Rutin 500 MG",{"intervention":2602,"totalTrials":333,"cells":2823},{"EARLY_PHASE1":2824,"PHASE1":2826,"PHASE2":2828,"PHASE3":2830,"PHASE4":2832,"NA":2838},{"trials":2825,"activeCount":99},[],{"trials":2827,"activeCount":99},[],{"trials":2829,"activeCount":99},[],{"trials":2831,"activeCount":99},[],{"trials":2833,"activeCount":99},[2834],{"nctId":2593,"briefTitle":2594,"status":134,"phases":2835,"primaryCompletion":79,"completion":79,"start":2596,"enrollment":125,"conditions":2836,"interventions":2837},[91],[2598,2599,2600],[2602,2603],{"trials":2839,"activeCount":99},[2840],{"nctId":2841,"briefTitle":2842,"status":278,"phases":2843,"primaryCompletion":2844,"completion":2845,"start":2846,"enrollment":154,"conditions":2847,"interventions":2849},"NCT04463966","Prevention of Postpartum Haemorrhage",[92],"2021-04","2021-05","2020-04-30",[2848],"Post Partum Hemorrhage",[2602],{"intervention":2851,"totalTrials":333,"cells":2852},"intrathecal dexmedetomidine",{"EARLY_PHASE1":2853,"PHASE1":2855,"PHASE2":2857,"PHASE3":2859,"PHASE4":2861,"NA":2863},{"trials":2854,"activeCount":99},[],{"trials":2856,"activeCount":99},[],{"trials":2858,"activeCount":99},[],{"trials":2860,"activeCount":99},[],{"trials":2862,"activeCount":99},[],{"trials":2864,"activeCount":99},[2865,2876],{"nctId":2866,"briefTitle":2867,"status":278,"phases":2868,"primaryCompletion":2869,"completion":2870,"start":2844,"enrollment":2871,"conditions":2872,"interventions":2873},"NCT04747171","Intrathecal Additives for Spinal Anaesthesia in Elective Caesarean Sections",[92],"2021-06","2021-07",105,[18],[2874,2875,2851],"intrathecal Magnesium","intrathecal dexamthasone",{"nctId":2877,"briefTitle":2878,"status":278,"phases":2879,"primaryCompletion":2880,"completion":2881,"start":2882,"enrollment":2883,"conditions":2884,"interventions":2885},"NCT04697745","Dexamethasone and Dexmedetomidine as an Adjuvant to Spinal Anesthesia for Elective Caesarean Sections",[92],"2021-04-30","2021-05-30","2021-03-01",44,[18],[2886,2887],"Intrathecal dexamethasone","Intrathecal dexmedetomidine",{"intervention":2889,"totalTrials":333,"cells":2890},"Triamcinolone Acetonide",{"EARLY_PHASE1":2891,"PHASE1":2893,"PHASE2":2895,"PHASE3":2897,"PHASE4":2911,"NA":2913},{"trials":2892,"activeCount":99},[],{"trials":2894,"activeCount":99},[],{"trials":2896,"activeCount":99},[],{"trials":2898,"activeCount":99},[2899],{"nctId":2900,"briefTitle":2901,"status":278,"phases":2902,"primaryCompletion":2903,"completion":214,"start":2904,"enrollment":229,"conditions":2905,"interventions":2910},"NCT05337332","Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases",[89,90],"2023-05-30","2022-04-14",[2906,2907,2908,2909],"Central Serous Chorioretinopathy","Irvine-Gass Syndrome","Pars Planitis","Cystoid Macular Edema",[2889],{"trials":2912,"activeCount":99},[],{"trials":2914,"activeCount":99},[2915],{"nctId":2916,"briefTitle":2917,"status":134,"phases":2918,"primaryCompletion":2919,"completion":2919,"start":2920,"enrollment":154,"conditions":2921,"interventions":2923},"NCT07194135","Intra-articular Tenoxicam Versus Triamcinolone Acetonide in Knee Osteoarthritis Management",[92],"2025-04-30","2024-11-03",[2922],"Osteoarthritis, Knee",[2924,2889],"Tenoxicam",{"intervention":523,"totalTrials":333,"cells":2926},{"EARLY_PHASE1":2927,"PHASE1":2929,"PHASE2":2931,"PHASE3":2933,"PHASE4":2935,"NA":2937},{"trials":2928,"activeCount":99},[],{"trials":2930,"activeCount":99},[],{"trials":2932,"activeCount":99},[],{"trials":2934,"activeCount":99},[],{"trials":2936,"activeCount":99},[],{"trials":2938,"activeCount":99},[2939,2943],{"nctId":512,"briefTitle":513,"status":134,"phases":2940,"primaryCompletion":515,"completion":516,"start":517,"enrollment":518,"conditions":2941,"interventions":2942},[92],[520],[85,522,523],{"nctId":2944,"briefTitle":2945,"status":134,"phases":2946,"primaryCompletion":2947,"completion":312,"start":2948,"enrollment":2871,"conditions":2949,"interventions":2951},"NCT06625606","Continuous Versus Single-Shot Spinal Anesthesia for Orthopedic Surgery",[92],"2024-11-15","2024-09-10",[2950],"Post Operative Pain",[523,523,2952],"Isoflurane Inhalant Product",{"intervention":2723,"totalTrials":333,"cells":2954},{"EARLY_PHASE1":2955,"PHASE1":2957,"PHASE2":2959,"PHASE3":2961,"PHASE4":2963,"NA":2972},{"trials":2956,"activeCount":99},[],{"trials":2958,"activeCount":99},[],{"trials":2960,"activeCount":99},[],{"trials":2962,"activeCount":99},[],{"trials":2964,"activeCount":99},[2965],{"nctId":2966,"briefTitle":2967,"status":134,"phases":2968,"primaryCompletion":54,"completion":2969,"start":726,"enrollment":290,"conditions":2970,"interventions":2971},"NCT07602608","Platelet-Rich Plasma With or Without Tadalafil for Erectile Dysfunction",[91],"2025-12-16",[1823],[2723],{"trials":2973,"activeCount":99},[2974],{"nctId":2716,"briefTitle":2717,"status":134,"phases":2975,"primaryCompletion":2643,"completion":2643,"start":2719,"enrollment":2720,"conditions":2976,"interventions":2977},[92],[2711,2722,2723,2690],[2690,2723,2725],{"intervention":2979,"totalTrials":333,"cells":2980},"Sildosin group",{"EARLY_PHASE1":2981,"PHASE1":2983,"PHASE2":2985,"PHASE3":2991,"PHASE4":2993,"NA":2995},{"trials":2982,"activeCount":99},[],{"trials":2984,"activeCount":99},[],{"trials":2986,"activeCount":99},[2987],{"nctId":2293,"briefTitle":2294,"status":278,"phases":2988,"primaryCompletion":2296,"completion":2297,"start":2298,"enrollment":361,"conditions":2989,"interventions":2990},[89],[2300],[2284,2302],{"trials":2992,"activeCount":99},[],{"trials":2994,"activeCount":99},[],{"trials":2996,"activeCount":99},[2997],{"nctId":2998,"briefTitle":2999,"status":134,"phases":3000,"primaryCompletion":2615,"completion":2615,"start":498,"enrollment":2481,"conditions":3001,"interventions":3005},"NCT05798572","Pre-Op Sildosine and Ureteral Dilation During F-URS",[92],[3002,3003,3004],"FURS","Ureteral Dilatation","Sildosine",[2979],{"intervention":2619,"totalTrials":117,"cells":3007},{"EARLY_PHASE1":3008,"PHASE1":3010,"PHASE2":3012,"PHASE3":3014,"PHASE4":3016,"NA":3018},{"trials":3009,"activeCount":99},[],{"trials":3011,"activeCount":99},[],{"trials":3013,"activeCount":99},[],{"trials":3015,"activeCount":99},[],{"trials":3017,"activeCount":99},[],{"trials":3019,"activeCount":99},[3020],{"nctId":2611,"briefTitle":2612,"status":134,"phases":3021,"primaryCompletion":2614,"completion":1993,"start":2615,"enrollment":154,"conditions":3022,"interventions":3023},[92],[2617],[2619,331],{"intervention":3025,"totalTrials":117,"cells":3026},"Antihypertensive Agents",{"EARLY_PHASE1":3027,"PHASE1":3029,"PHASE2":3031,"PHASE3":3033,"PHASE4":3035,"NA":3037},{"trials":3028,"activeCount":99},[],{"trials":3030,"activeCount":99},[],{"trials":3032,"activeCount":99},[],{"trials":3034,"activeCount":99},[],{"trials":3036,"activeCount":99},[],{"trials":3038,"activeCount":99},[3039],{"nctId":3040,"briefTitle":3041,"status":278,"phases":3042,"primaryCompletion":3043,"completion":3044,"start":3045,"enrollment":448,"conditions":3046,"interventions":3051},"NCT05328921","Effects of Systemic Drugs on Intraocular Pressure",[],"2022-09-15","2022-09-30","2022-04-07",[3047,3048,3049,3050],"Glaucoma, Angle-Closure","Glaucoma Suspect","Glaucoma Secondary to Drugs, Bilateral","Hypertension",[3025,3052],"Antihistaminics",{"intervention":3052,"totalTrials":117,"cells":3054},{"EARLY_PHASE1":3055,"PHASE1":3057,"PHASE2":3059,"PHASE3":3061,"PHASE4":3063,"NA":3065},{"trials":3056,"activeCount":99},[],{"trials":3058,"activeCount":99},[],{"trials":3060,"activeCount":99},[],{"trials":3062,"activeCount":99},[],{"trials":3064,"activeCount":99},[],{"trials":3066,"activeCount":99},[3067],{"nctId":3040,"briefTitle":3041,"status":278,"phases":3068,"primaryCompletion":3043,"completion":3044,"start":3045,"enrollment":448,"conditions":3069,"interventions":3070},[],[3047,3048,3049,3050],[3025,3052],{"intervention":3072,"totalTrials":117,"cells":3073},"Blood Lactate",{"EARLY_PHASE1":3074,"PHASE1":3076,"PHASE2":3078,"PHASE3":3080,"PHASE4":3082,"NA":3084},{"trials":3075,"activeCount":99},[],{"trials":3077,"activeCount":99},[],{"trials":3079,"activeCount":99},[],{"trials":3081,"activeCount":99},[],{"trials":3083,"activeCount":99},[],{"trials":3085,"activeCount":99},[3086],{"nctId":3087,"briefTitle":3088,"status":134,"phases":3089,"primaryCompletion":3090,"completion":301,"start":3091,"enrollment":326,"conditions":3092,"interventions":3094},"NCT06640504","Serum Albumin Ratios Can Improve Sepsis Mortality Prediction",[],"2024-11-30","2024-09-30",[3093],"Sepsis",[3072],{"intervention":3096,"totalTrials":117,"cells":3097},"Melatonin 3 mg Sublingual",{"EARLY_PHASE1":3098,"PHASE1":3100,"PHASE2":3102,"PHASE3":3104,"PHASE4":3106,"NA":3108},{"trials":3099,"activeCount":99},[],{"trials":3101,"activeCount":99},[],{"trials":3103,"activeCount":99},[],{"trials":3105,"activeCount":99},[],{"trials":3107,"activeCount":99},[],{"trials":3109,"activeCount":99},[3110],{"nctId":3111,"briefTitle":3112,"status":134,"phases":3113,"primaryCompletion":3114,"completion":302,"start":3115,"enrollment":3116,"conditions":3117,"interventions":3118},"NCT06997263","Sublingual Melatonin for Anxiety and Pain in Elective Gynecologic Surgery",[92],"2025-01-10","2024-01-15",96,[190,28,114],[3096,3119],"Melatonin 6 mg Sublingual",{"intervention":3119,"totalTrials":117,"cells":3121},{"EARLY_PHASE1":3122,"PHASE1":3124,"PHASE2":3126,"PHASE3":3128,"PHASE4":3130,"NA":3132},{"trials":3123,"activeCount":99},[],{"trials":3125,"activeCount":99},[],{"trials":3127,"activeCount":99},[],{"trials":3129,"activeCount":99},[],{"trials":3131,"activeCount":99},[],{"trials":3133,"activeCount":99},[3134],{"nctId":3111,"briefTitle":3112,"status":134,"phases":3135,"primaryCompletion":3114,"completion":302,"start":3115,"enrollment":3116,"conditions":3136,"interventions":3137},[92],[190,28,114],[3096,3119],{"intervention":3139,"totalTrials":117,"cells":3140},"rapid acting insulin",{"EARLY_PHASE1":3141,"PHASE1":3143,"PHASE2":3145,"PHASE3":3147,"PHASE4":3149,"NA":3151},{"trials":3142,"activeCount":99},[],{"trials":3144,"activeCount":99},[],{"trials":3146,"activeCount":99},[],{"trials":3148,"activeCount":99},[],{"trials":3150,"activeCount":99},[],{"trials":3152,"activeCount":99},[3153],{"nctId":3154,"briefTitle":3155,"status":278,"phases":3156,"primaryCompletion":3157,"completion":1020,"start":3158,"enrollment":326,"conditions":3159,"interventions":3163},"NCT05940376","Topical Insulin in Neurotrophic Keratopathy After Diabetic Vitrectomy",[],"2023-08-01","2023-07-15",[3160,3161,3162],"Corneal Ulcer","Neurotrophic Corneal Ulcer","Diabetes Mellitus",[3139],{"intervention":3165,"totalTrials":117,"cells":3166},"Intervention 1: Brolucizumab",{"EARLY_PHASE1":3167,"PHASE1":3169,"PHASE2":3171,"PHASE3":3173,"PHASE4":3175,"NA":3177},{"trials":3168,"activeCount":99},[],{"trials":3170,"activeCount":99},[],{"trials":3172,"activeCount":99},[],{"trials":3174,"activeCount":99},[],{"trials":3176,"activeCount":99},[],{"trials":3178,"activeCount":99},[3179],{"nctId":3180,"briefTitle":3181,"status":134,"phases":3182,"primaryCompletion":212,"completion":212,"start":3183,"enrollment":3184,"conditions":3185,"interventions":3187},"NCT07096713","Brolucizumab Versus Aflibercept on Visual and Anatomical Outcomes in Diabetic Macular Edema",[92],"2024-01-01",38,[3186],"Anti-VEGF Therapy",[3165,3188],"Intervention 2: Aflibercept",{"intervention":3188,"totalTrials":117,"cells":3190},{"EARLY_PHASE1":3191,"PHASE1":3193,"PHASE2":3195,"PHASE3":3197,"PHASE4":3199,"NA":3201},{"trials":3192,"activeCount":99},[],{"trials":3194,"activeCount":99},[],{"trials":3196,"activeCount":99},[],{"trials":3198,"activeCount":99},[],{"trials":3200,"activeCount":99},[],{"trials":3202,"activeCount":99},[3203],{"nctId":3180,"briefTitle":3181,"status":134,"phases":3204,"primaryCompletion":212,"completion":212,"start":3183,"enrollment":3184,"conditions":3205,"interventions":3206},[92],[3186],[3165,3188],{"intervention":3208,"totalTrials":117,"cells":3209},"desmopressin 120 mcg oral",{"EARLY_PHASE1":3210,"PHASE1":3212,"PHASE2":3214,"PHASE3":3216,"PHASE4":3218,"NA":3220},{"trials":3211,"activeCount":99},[],{"trials":3213,"activeCount":99},[],{"trials":3215,"activeCount":99},[],{"trials":3217,"activeCount":99},[],{"trials":3219,"activeCount":99},[],{"trials":3221,"activeCount":99},[3222],{"nctId":3223,"briefTitle":3224,"status":278,"phases":3225,"primaryCompletion":3226,"completion":2436,"start":3227,"enrollment":1446,"conditions":3228,"interventions":3230},"NCT05617664","Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis",[92],"2023-09","2022-11-23",[3229],"Nocturnal Enuresis",[3208,3231],"Mirabegron 25 MG Oral Tablet, Extended Release",{"intervention":3231,"totalTrials":117,"cells":3233},{"EARLY_PHASE1":3234,"PHASE1":3236,"PHASE2":3238,"PHASE3":3240,"PHASE4":3242,"NA":3244},{"trials":3235,"activeCount":99},[],{"trials":3237,"activeCount":99},[],{"trials":3239,"activeCount":99},[],{"trials":3241,"activeCount":99},[],{"trials":3243,"activeCount":99},[],{"trials":3245,"activeCount":99},[3246],{"nctId":3223,"briefTitle":3224,"status":278,"phases":3247,"primaryCompletion":3226,"completion":2436,"start":3227,"enrollment":1446,"conditions":3248,"interventions":3249},[92],[3229],[3208,3231],{"intervention":3251,"totalTrials":117,"cells":3252},"Platelet rich plasma",{"EARLY_PHASE1":3253,"PHASE1":3255,"PHASE2":3257,"PHASE3":3259,"PHASE4":3261,"NA":3263},{"trials":3254,"activeCount":99},[],{"trials":3256,"activeCount":99},[],{"trials":3258,"activeCount":99},[],{"trials":3260,"activeCount":99},[],{"trials":3262,"activeCount":99},[],{"trials":3264,"activeCount":99},[3265],{"nctId":3266,"briefTitle":3267,"status":134,"phases":3268,"primaryCompletion":3269,"completion":3269,"start":3270,"enrollment":215,"conditions":3271,"interventions":3273},"NCT06849674","Efficacy and Safety of Platelet-Rich Plasma as an Intraoperative Holding Solution in Hair Transplantation",[92],"2024-11-28","2023-05-23",[3272],"Hair Transplantation",[3251],{"intervention":3275,"totalTrials":117,"cells":3276},"Anti-vascular endothelial growth factors",{"EARLY_PHASE1":3277,"PHASE1":3279,"PHASE2":3281,"PHASE3":3283,"PHASE4":3285,"NA":3287},{"trials":3278,"activeCount":99},[],{"trials":3280,"activeCount":99},[],{"trials":3282,"activeCount":99},[],{"trials":3284,"activeCount":99},[],{"trials":3286,"activeCount":99},[],{"trials":3288,"activeCount":99},[3289],{"nctId":3290,"briefTitle":3291,"status":278,"phases":3292,"primaryCompletion":3293,"completion":2654,"start":3294,"enrollment":2359,"conditions":3295,"interventions":3300},"NCT05494775","Effect of Corona Virus on Intravitreal Injections",[92],"2023-06-11","2019-02-01",[2657,3296,3297,3298,3299],"Age-Related Macular Degeneration","Choroidal Neovascularization","Myopic Choroidal Neovascularisation","Diabetic Retinopathy",[3275],{"intervention":3302,"totalTrials":117,"cells":3303},"Misoprostol 200mcg Tab",{"EARLY_PHASE1":3304,"PHASE1":3306,"PHASE2":3308,"PHASE3":3310,"PHASE4":3312,"NA":3314},{"trials":3305,"activeCount":99},[],{"trials":3307,"activeCount":99},[],{"trials":3309,"activeCount":99},[],{"trials":3311,"activeCount":99},[],{"trials":3313,"activeCount":99},[],{"trials":3315,"activeCount":99},[3316],{"nctId":3317,"briefTitle":3318,"status":134,"phases":3319,"primaryCompletion":3320,"completion":3321,"start":3322,"enrollment":3323,"conditions":3324,"interventions":3327},"NCT07271056","Sublingual Misoprostol Versus No Cervical Priming Before Hysteroscopic Resection of Symptomatic Uterine Niches",[92],"2025-07-30","2025-10-30","2025-02-11",56,[3325,3326,23],"Scar Niche","Abnormal Uterine Bleeding",[3302],{"intervention":234,"totalTrials":117,"cells":3329},{"EARLY_PHASE1":3330,"PHASE1":3332,"PHASE2":3334,"PHASE3":3336,"PHASE4":3338,"NA":3340},{"trials":3331,"activeCount":99},[],{"trials":3333,"activeCount":99},[],{"trials":3335,"activeCount":99},[],{"trials":3337,"activeCount":99},[],{"trials":3339,"activeCount":99},[],{"trials":3341,"activeCount":99},[3342],{"nctId":223,"briefTitle":224,"status":134,"phases":3343,"primaryCompletion":226,"completion":227,"start":228,"enrollment":229,"conditions":3344,"interventions":3345},[92],[231,232],[172,234],{"intervention":3347,"totalTrials":117,"cells":3348},"Cholecalciferol",{"EARLY_PHASE1":3349,"PHASE1":3351,"PHASE2":3353,"PHASE3":3355,"PHASE4":3357,"NA":3359},{"trials":3350,"activeCount":99},[],{"trials":3352,"activeCount":99},[],{"trials":3354,"activeCount":99},[],{"trials":3356,"activeCount":99},[],{"trials":3358,"activeCount":99},[],{"trials":3360,"activeCount":99},[3361],{"nctId":3362,"briefTitle":3363,"status":134,"phases":3364,"primaryCompletion":3365,"completion":3365,"start":1210,"enrollment":215,"conditions":3366,"interventions":3369},"NCT04793529","Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study",[92],"2019-10-01",[3367,3368],"Verruca Vulgaris","Involucrin",[3347],{"intervention":3371,"totalTrials":117,"cells":3372},"Tacrolimus ointment",{"EARLY_PHASE1":3373,"PHASE1":3375,"PHASE2":3377,"PHASE3":3379,"PHASE4":3381,"NA":3383},{"trials":3374,"activeCount":99},[],{"trials":3376,"activeCount":99},[],{"trials":3378,"activeCount":99},[],{"trials":3380,"activeCount":99},[],{"trials":3382,"activeCount":99},[],{"trials":3384,"activeCount":99},[3385],{"nctId":3386,"briefTitle":3387,"status":134,"phases":3388,"primaryCompletion":1744,"completion":3389,"start":1247,"enrollment":2325,"conditions":3390,"interventions":3391},"NCT04267991","Corneal Densitometry Changes With Adenoviral SEI",[],"2020-04-15",[1066],[3371],{"intervention":3393,"totalTrials":117,"cells":3394},"sevoflurane",{"EARLY_PHASE1":3395,"PHASE1":3397,"PHASE2":3399,"PHASE3":3401,"PHASE4":3403,"NA":3405},{"trials":3396,"activeCount":99},[],{"trials":3398,"activeCount":99},[],{"trials":3400,"activeCount":99},[],{"trials":3402,"activeCount":99},[],{"trials":3404,"activeCount":99},[],{"trials":3406,"activeCount":99},[3407],{"nctId":3408,"briefTitle":3409,"status":278,"phases":3410,"primaryCompletion":3411,"completion":3412,"start":1526,"enrollment":125,"conditions":3413,"interventions":3417},"NCT06396468","Sevoflurane and Intravenous Anesthesia in Hypospadias Repair",[92],"2024-06-26","2024-07-26",[3414,3415,3416],"Emergence Delirium","Intravenous Anesthesia","Sevoflurane",[3393,3418],"propofol",{"intervention":3418,"totalTrials":117,"cells":3420},{"EARLY_PHASE1":3421,"PHASE1":3423,"PHASE2":3425,"PHASE3":3427,"PHASE4":3429,"NA":3431},{"trials":3422,"activeCount":99},[],{"trials":3424,"activeCount":99},[],{"trials":3426,"activeCount":99},[],{"trials":3428,"activeCount":99},[],{"trials":3430,"activeCount":99},[],{"trials":3432,"activeCount":99},[3433],{"nctId":3408,"briefTitle":3409,"status":278,"phases":3434,"primaryCompletion":3411,"completion":3412,"start":1526,"enrollment":125,"conditions":3435,"interventions":3436},[92],[3414,3415,3416],[3393,3418],{"intervention":3438,"totalTrials":117,"cells":3439},"monophasic combined oral contraceptive pill",{"EARLY_PHASE1":3440,"PHASE1":3442,"PHASE2":3444,"PHASE3":3446,"PHASE4":3448,"NA":3450},{"trials":3441,"activeCount":99},[],{"trials":3443,"activeCount":99},[],{"trials":3445,"activeCount":99},[],{"trials":3447,"activeCount":99},[],{"trials":3449,"activeCount":99},[],{"trials":3451,"activeCount":99},[3452],{"nctId":3453,"briefTitle":3454,"status":134,"phases":3455,"primaryCompletion":971,"completion":1105,"start":3456,"enrollment":3457,"conditions":3458,"interventions":3460},"NCT07229209","Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding",[92],"2025-02-05",166,[3326,23,3459],"Uterine Scar",[3438],{"intervention":3462,"totalTrials":117,"cells":3463},"Fluconazole 150 mg",{"EARLY_PHASE1":3464,"PHASE1":3466,"PHASE2":3468,"PHASE3":3470,"PHASE4":3472,"NA":3474},{"trials":3465,"activeCount":99},[],{"trials":3467,"activeCount":99},[],{"trials":3469,"activeCount":99},[],{"trials":3471,"activeCount":99},[],{"trials":3473,"activeCount":99},[],{"trials":3475,"activeCount":99},[3476],{"nctId":3477,"briefTitle":3478,"status":278,"phases":3479,"primaryCompletion":1063,"completion":1063,"start":3480,"enrollment":3481,"conditions":3482,"interventions":3484},"NCT04947592","SD-OCT Guided Treatment of Fungal Chorioretinitis",[],"2020-01-15",10,[3483],"Fungal Retinitis",[3462],{"intervention":2874,"totalTrials":117,"cells":3486},{"EARLY_PHASE1":3487,"PHASE1":3489,"PHASE2":3491,"PHASE3":3493,"PHASE4":3495,"NA":3497},{"trials":3488,"activeCount":99},[],{"trials":3490,"activeCount":99},[],{"trials":3492,"activeCount":99},[],{"trials":3494,"activeCount":99},[],{"trials":3496,"activeCount":99},[],{"trials":3498,"activeCount":99},[3499],{"nctId":2866,"briefTitle":2867,"status":278,"phases":3500,"primaryCompletion":2869,"completion":2870,"start":2844,"enrollment":2871,"conditions":3501,"interventions":3502},[92],[18],[2874,2875,2851],{"intervention":2875,"totalTrials":117,"cells":3504},{"EARLY_PHASE1":3505,"PHASE1":3507,"PHASE2":3509,"PHASE3":3511,"PHASE4":3513,"NA":3515},{"trials":3506,"activeCount":99},[],{"trials":3508,"activeCount":99},[],{"trials":3510,"activeCount":99},[],{"trials":3512,"activeCount":99},[],{"trials":3514,"activeCount":99},[],{"trials":3516,"activeCount":99},[3517],{"nctId":2866,"briefTitle":2867,"status":278,"phases":3518,"primaryCompletion":2869,"completion":2870,"start":2844,"enrollment":2871,"conditions":3519,"interventions":3520},[92],[18],[2874,2875,2851],{"intervention":522,"totalTrials":117,"cells":3522},{"EARLY_PHASE1":3523,"PHASE1":3525,"PHASE2":3527,"PHASE3":3529,"PHASE4":3531,"NA":3533},{"trials":3524,"activeCount":99},[],{"trials":3526,"activeCount":99},[],{"trials":3528,"activeCount":99},[],{"trials":3530,"activeCount":99},[],{"trials":3532,"activeCount":99},[],{"trials":3534,"activeCount":99},[3535],{"nctId":512,"briefTitle":513,"status":134,"phases":3536,"primaryCompletion":515,"completion":516,"start":517,"enrollment":518,"conditions":3537,"interventions":3538},[92],[520],[85,522,523],{"intervention":3540,"totalTrials":117,"cells":3541},"Hepatitis B recombinant DNA vaccine",{"EARLY_PHASE1":3542,"PHASE1":3544,"PHASE2":3546,"PHASE3":3548,"PHASE4":3550,"NA":3552},{"trials":3543,"activeCount":99},[],{"trials":3545,"activeCount":99},[],{"trials":3547,"activeCount":99},[],{"trials":3549,"activeCount":99},[],{"trials":3551,"activeCount":99},[],{"trials":3553,"activeCount":99},[3554],{"nctId":3555,"briefTitle":3556,"status":134,"phases":3557,"primaryCompletion":3558,"completion":1865,"start":3559,"enrollment":168,"conditions":3560,"interventions":3563},"NCT03149874","Accelerated Vaccination Schedule Against Hepatitis B Virus With Combined Hepatitis A and B Vaccine Among Hemodialysis Patients",[92],"2017-04-30","2014-12-01",[3561,3562],"Hepatitis B","Hemodialysis Complication",[3540,3564],"Combined hepatitis A and B vaccine",{"intervention":3564,"totalTrials":117,"cells":3566},{"EARLY_PHASE1":3567,"PHASE1":3569,"PHASE2":3571,"PHASE3":3573,"PHASE4":3575,"NA":3577},{"trials":3568,"activeCount":99},[],{"trials":3570,"activeCount":99},[],{"trials":3572,"activeCount":99},[],{"trials":3574,"activeCount":99},[],{"trials":3576,"activeCount":99},[],{"trials":3578,"activeCount":99},[3579],{"nctId":3555,"briefTitle":3556,"status":134,"phases":3580,"primaryCompletion":3558,"completion":1865,"start":3559,"enrollment":168,"conditions":3581,"interventions":3582},[92],[3561,3562],[3540,3564],{"intervention":3584,"totalTrials":117,"cells":3585},"buccal midazolam +oral placebo syrup",{"EARLY_PHASE1":3586,"PHASE1":3588,"PHASE2":3590,"PHASE3":3592,"PHASE4":3594,"NA":3596},{"trials":3587,"activeCount":99},[],{"trials":3589,"activeCount":99},[],{"trials":3591,"activeCount":99},[],{"trials":3593,"activeCount":99},[],{"trials":3595,"activeCount":99},[],{"trials":3597,"activeCount":99},[3598],{"nctId":3599,"briefTitle":3600,"status":134,"phases":3601,"primaryCompletion":3602,"completion":3603,"start":3604,"enrollment":561,"conditions":3605,"interventions":3607},"NCT06389318","Buccal Midazolam Versus Intranasal Dexmedetomidine Plus Oral Chloral Hydrate in Inguinal Hernia Repair",[92],"2024-03-26","2024-04-24","2023-03-26",[3606],"Inguinal Hernia Repair",[3584,3608],"oral chloral hydrate,intranasal dexmedetomidine and buccal normal saline",{"intervention":3608,"totalTrials":117,"cells":3610},{"EARLY_PHASE1":3611,"PHASE1":3613,"PHASE2":3615,"PHASE3":3617,"PHASE4":3619,"NA":3621},{"trials":3612,"activeCount":99},[],{"trials":3614,"activeCount":99},[],{"trials":3616,"activeCount":99},[],{"trials":3618,"activeCount":99},[],{"trials":3620,"activeCount":99},[],{"trials":3622,"activeCount":99},[3623],{"nctId":3599,"briefTitle":3600,"status":134,"phases":3624,"primaryCompletion":3602,"completion":3603,"start":3604,"enrollment":561,"conditions":3625,"interventions":3626},[92],[3606],[3584,3608],{"intervention":159,"totalTrials":117,"cells":3628},{"EARLY_PHASE1":3629,"PHASE1":3631,"PHASE2":3633,"PHASE3":3635,"PHASE4":3637,"NA":3639},{"trials":3630,"activeCount":99},[],{"trials":3632,"activeCount":99},[],{"trials":3634,"activeCount":99},[],{"trials":3636,"activeCount":99},[],{"trials":3638,"activeCount":99},[],{"trials":3640,"activeCount":99},[3641],{"nctId":148,"briefTitle":149,"status":134,"phases":3642,"primaryCompletion":151,"completion":152,"start":153,"enrollment":154,"conditions":3643,"interventions":3644},[92],[156],[95,158,159,160],{"intervention":3646,"totalTrials":117,"cells":3647},"Post-operative application of CsA",{"EARLY_PHASE1":3648,"PHASE1":3650,"PHASE2":3652,"PHASE3":3654,"PHASE4":3656,"NA":3658},{"trials":3649,"activeCount":99},[],{"trials":3651,"activeCount":99},[],{"trials":3653,"activeCount":99},[],{"trials":3655,"activeCount":99},[],{"trials":3657,"activeCount":99},[],{"trials":3659,"activeCount":99},[3660],{"nctId":3661,"briefTitle":3662,"status":134,"phases":3663,"primaryCompletion":3091,"completion":3664,"start":3665,"enrollment":242,"conditions":3666,"interventions":3669},"NCT06944132","CsA vs MMC for Preventing Pterygium Recurrence",[92],"2024-10-15","2024-04-01",[3667,3668],"Pterygium","Pterygium of the Conjunctiva and Cornea",[3646,3670],"Intra-operative application of MMC",{"intervention":3670,"totalTrials":117,"cells":3672},{"EARLY_PHASE1":3673,"PHASE1":3675,"PHASE2":3677,"PHASE3":3679,"PHASE4":3681,"NA":3683},{"trials":3674,"activeCount":99},[],{"trials":3676,"activeCount":99},[],{"trials":3678,"activeCount":99},[],{"trials":3680,"activeCount":99},[],{"trials":3682,"activeCount":99},[],{"trials":3684,"activeCount":99},[3685],{"nctId":3661,"briefTitle":3662,"status":134,"phases":3686,"primaryCompletion":3091,"completion":3664,"start":3665,"enrollment":242,"conditions":3687,"interventions":3688},[92],[3667,3668],[3646,3670],{"intervention":3690,"totalTrials":117,"cells":3691},"Alpha lipoic acid",{"EARLY_PHASE1":3692,"PHASE1":3694,"PHASE2":3696,"PHASE3":3698,"PHASE4":3700,"NA":3702},{"trials":3693,"activeCount":99},[],{"trials":3695,"activeCount":99},[],{"trials":3697,"activeCount":99},[],{"trials":3699,"activeCount":99},[],{"trials":3701,"activeCount":99},[],{"trials":3703,"activeCount":99},[3704],{"nctId":3705,"briefTitle":3706,"status":134,"phases":3707,"primaryCompletion":3708,"completion":3709,"start":3710,"enrollment":125,"conditions":3711,"interventions":3714},"NCT04322240","Alpha Lipoic Acid and Diabetes Mellitus: Potential Effects on Peripheral Neuropathy",[92],"2020-10-23","2020-12-23","2020-04-02",[3712,3713],"Diabetic Polyneuropathy","Diabetes Mellitus, Type 2",[3690],{"intervention":3716,"totalTrials":117,"cells":3717},"intravitreal",{"EARLY_PHASE1":3718,"PHASE1":3720,"PHASE2":3722,"PHASE3":3724,"PHASE4":3726,"NA":3728},{"trials":3719,"activeCount":99},[],{"trials":3721,"activeCount":99},[],{"trials":3723,"activeCount":99},[],{"trials":3725,"activeCount":99},[],{"trials":3727,"activeCount":99},[],{"trials":3729,"activeCount":99},[3730],{"nctId":3731,"briefTitle":3732,"status":278,"phases":3733,"primaryCompletion":3734,"completion":1793,"start":3735,"enrollment":242,"conditions":3736,"interventions":3738},"NCT04882956","BEOVU Versus Eylea in the Treatment of Age-related Macular Neovascular Degeneration",[92],"2021-12","2020-08-05",[3737],"Macula Lutea Degeneration",[3716,3716],{"intervention":2886,"totalTrials":117,"cells":3740},{"EARLY_PHASE1":3741,"PHASE1":3743,"PHASE2":3745,"PHASE3":3747,"PHASE4":3749,"NA":3751},{"trials":3742,"activeCount":99},[],{"trials":3744,"activeCount":99},[],{"trials":3746,"activeCount":99},[],{"trials":3748,"activeCount":99},[],{"trials":3750,"activeCount":99},[],{"trials":3752,"activeCount":99},[3753],{"nctId":2877,"briefTitle":2878,"status":278,"phases":3754,"primaryCompletion":2880,"completion":2881,"start":2882,"enrollment":2883,"conditions":3755,"interventions":3756},[92],[18],[2886,2887],{"intervention":3758,"totalTrials":117,"cells":3759},"Dexamethasone Ophthalmic implant",{"EARLY_PHASE1":3760,"PHASE1":3762,"PHASE2":3764,"PHASE3":3766,"PHASE4":3768,"NA":3770},{"trials":3761,"activeCount":99},[],{"trials":3763,"activeCount":99},[],{"trials":3765,"activeCount":99},[],{"trials":3767,"activeCount":99},[],{"trials":3769,"activeCount":99},[],{"trials":3771,"activeCount":99},[3772],{"nctId":3773,"briefTitle":3774,"status":134,"phases":3775,"primaryCompletion":3776,"completion":3776,"start":2781,"enrollment":3777,"conditions":3778,"interventions":3780},"NCT03971279","Dexamethasone Intravitreal Implant (Ozurdex®) for Recurrent Vogt-Koyanagi-Harada (VKH) Disease Posterior Uveitis",[],"2019-11-22",16,[3779],"Posterior Uveitis",[3758],{"intervention":3782,"totalTrials":117,"cells":3783},"Sildenafil Citrate vaginal suppositories",{"EARLY_PHASE1":3784,"PHASE1":3786,"PHASE2":3788,"PHASE3":3790,"PHASE4":3792,"NA":3794},{"trials":3785,"activeCount":99},[],{"trials":3787,"activeCount":99},[],{"trials":3789,"activeCount":99},[],{"trials":3791,"activeCount":99},[],{"trials":3793,"activeCount":99},[],{"trials":3795,"activeCount":99},[3796],{"nctId":3797,"briefTitle":3798,"status":134,"phases":3799,"primaryCompletion":3800,"completion":3800,"start":3801,"enrollment":3802,"conditions":3803,"interventions":3805},"NCT03475160","Sildenafil Citrate and Recurrent Abortion",[92],"2017-12-01","2015-12-01",130,[3804],"Recurrent Abortion",[3782],{"intervention":287,"totalTrials":117,"cells":3807},{"EARLY_PHASE1":3808,"PHASE1":3810,"PHASE2":3812,"PHASE3":3814,"PHASE4":3816,"NA":3818},{"trials":3809,"activeCount":99},[],{"trials":3811,"activeCount":99},[],{"trials":3813,"activeCount":99},[],{"trials":3815,"activeCount":99},[],{"trials":3817,"activeCount":99},[],{"trials":3819,"activeCount":99},[3820],{"nctId":276,"briefTitle":277,"status":278,"phases":3821,"primaryCompletion":280,"completion":281,"start":282,"enrollment":283,"conditions":3822,"interventions":3823},[92],[285],[287,172],{"intervention":2952,"totalTrials":117,"cells":3825},{"EARLY_PHASE1":3826,"PHASE1":3828,"PHASE2":3830,"PHASE3":3832,"PHASE4":3834,"NA":3836},{"trials":3827,"activeCount":99},[],{"trials":3829,"activeCount":99},[],{"trials":3831,"activeCount":99},[],{"trials":3833,"activeCount":99},[],{"trials":3835,"activeCount":99},[],{"trials":3837,"activeCount":99},[3838],{"nctId":2944,"briefTitle":2945,"status":134,"phases":3839,"primaryCompletion":2947,"completion":312,"start":2948,"enrollment":2871,"conditions":3840,"interventions":3841},[92],[2950],[523,523,2952],{"intervention":3843,"totalTrials":117,"cells":3844},"Solifenacin group",{"EARLY_PHASE1":3845,"PHASE1":3847,"PHASE2":3849,"PHASE3":3851,"PHASE4":3853,"NA":3855},{"trials":3846,"activeCount":99},[],{"trials":3848,"activeCount":99},[],{"trials":3850,"activeCount":99},[],{"trials":3852,"activeCount":99},[],{"trials":3854,"activeCount":99},[],{"trials":3856,"activeCount":99},[3857],{"nctId":3858,"briefTitle":3859,"status":134,"phases":3860,"primaryCompletion":3861,"completion":3861,"start":3862,"enrollment":3863,"conditions":3864,"interventions":3867},"NCT05911594","IDB Injection Combined With PTNS for Managing Children With OAB Not Responding to Monotherapy",[92],"2023-02-14","2022-02-14",128,[3865,3866],"BOTOX","Percutaneous Tibial Nerve Stimulation",[3843,3868,3869],"Intradetrusor BOTOX group","Intradetrusor BOTOX combined with Percutaneous tibial nerve stimulation group",{"intervention":3868,"totalTrials":117,"cells":3871},{"EARLY_PHASE1":3872,"PHASE1":3874,"PHASE2":3876,"PHASE3":3878,"PHASE4":3880,"NA":3882},{"trials":3873,"activeCount":99},[],{"trials":3875,"activeCount":99},[],{"trials":3877,"activeCount":99},[],{"trials":3879,"activeCount":99},[],{"trials":3881,"activeCount":99},[],{"trials":3883,"activeCount":99},[3884],{"nctId":3858,"briefTitle":3859,"status":134,"phases":3885,"primaryCompletion":3861,"completion":3861,"start":3862,"enrollment":3863,"conditions":3886,"interventions":3887},[92],[3865,3866],[3843,3868,3869],{"intervention":3869,"totalTrials":117,"cells":3889},{"EARLY_PHASE1":3890,"PHASE1":3892,"PHASE2":3894,"PHASE3":3896,"PHASE4":3898,"NA":3900},{"trials":3891,"activeCount":99},[],{"trials":3893,"activeCount":99},[],{"trials":3895,"activeCount":99},[],{"trials":3897,"activeCount":99},[],{"trials":3899,"activeCount":99},[],{"trials":3901,"activeCount":99},[3902],{"nctId":3858,"briefTitle":3859,"status":134,"phases":3903,"primaryCompletion":3861,"completion":3861,"start":3862,"enrollment":3863,"conditions":3904,"interventions":3905},[92],[3865,3866],[3843,3868,3869],{"intervention":3907,"totalTrials":117,"cells":3908},"Erector spinae plane block",{"EARLY_PHASE1":3909,"PHASE1":3911,"PHASE2":3913,"PHASE3":3915,"PHASE4":3917,"NA":3919},{"trials":3910,"activeCount":99},[],{"trials":3912,"activeCount":99},[],{"trials":3914,"activeCount":99},[],{"trials":3916,"activeCount":99},[],{"trials":3918,"activeCount":99},[],{"trials":3920,"activeCount":99},[3921],{"nctId":3922,"briefTitle":3923,"status":278,"phases":3924,"primaryCompletion":3925,"completion":3926,"start":2845,"enrollment":3927,"conditions":3928,"interventions":3929},"NCT04749095","Erector Spinae Plane Block Analgesia for Lumbar Spine Fusion Surgery",[92],"2021-08","2021-09",45,[18],[3907,3930],"sham subcutaneous infiltration",{"intervention":3930,"totalTrials":117,"cells":3932},{"EARLY_PHASE1":3933,"PHASE1":3935,"PHASE2":3937,"PHASE3":3939,"PHASE4":3941,"NA":3943},{"trials":3934,"activeCount":99},[],{"trials":3936,"activeCount":99},[],{"trials":3938,"activeCount":99},[],{"trials":3940,"activeCount":99},[],{"trials":3942,"activeCount":99},[],{"trials":3944,"activeCount":99},[3945],{"nctId":3922,"briefTitle":3923,"status":278,"phases":3946,"primaryCompletion":3925,"completion":3926,"start":2845,"enrollment":3927,"conditions":3947,"interventions":3948},[92],[18],[3907,3930],{"intervention":3950,"totalTrials":117,"cells":3951},"Tranexamic Acid group",{"EARLY_PHASE1":3952,"PHASE1":3954,"PHASE2":3956,"PHASE3":3958,"PHASE4":3960,"NA":3962},{"trials":3953,"activeCount":99},[],{"trials":3955,"activeCount":99},[],{"trials":3957,"activeCount":99},[],{"trials":3959,"activeCount":99},[],{"trials":3961,"activeCount":99},[],{"trials":3963,"activeCount":99},[3964],{"nctId":3965,"briefTitle":3966,"status":278,"phases":3967,"primaryCompletion":3968,"completion":3968,"start":3969,"enrollment":215,"conditions":3970,"interventions":3974},"NCT05913466","Intraprostatic Injection of Tranexamic Acid Decrease Blood Loss During Monopolar TURP",[92],"2024-06-20","2023-06-20",[3971,3972,3973],"Benign Prostatic Hyperplasia","Transurethral Resection of the Prostate","Tranexamic Acid",[3950,3975],"Distilled water group",{"intervention":3975,"totalTrials":117,"cells":3977},{"EARLY_PHASE1":3978,"PHASE1":3980,"PHASE2":3982,"PHASE3":3984,"PHASE4":3986,"NA":3988},{"trials":3979,"activeCount":99},[],{"trials":3981,"activeCount":99},[],{"trials":3983,"activeCount":99},[],{"trials":3985,"activeCount":99},[],{"trials":3987,"activeCount":99},[],{"trials":3989,"activeCount":99},[3990],{"nctId":3965,"briefTitle":3966,"status":278,"phases":3991,"primaryCompletion":3968,"completion":3968,"start":3969,"enrollment":215,"conditions":3992,"interventions":3993},[92],[3971,3972,3973],[3950,3975],{"intervention":3995,"totalTrials":117,"cells":3996},"Multimodal IV analgesia",{"EARLY_PHASE1":3997,"PHASE1":3999,"PHASE2":4001,"PHASE3":4003,"PHASE4":4005,"NA":4007},{"trials":3998,"activeCount":99},[],{"trials":4000,"activeCount":99},[],{"trials":4002,"activeCount":99},[],{"trials":4004,"activeCount":99},[],{"trials":4006,"activeCount":99},[],{"trials":4008,"activeCount":99},[4009],{"nctId":4010,"briefTitle":4011,"status":134,"phases":4012,"primaryCompletion":4013,"completion":2947,"start":4014,"enrollment":154,"conditions":4015,"interventions":4016},"NCT06661746","Efficient Postoperative Pain Management With Multimodal IV",[92],"2024-10-30","2024-07-15",[2950],[3995,4017],"epidural analgesia",{"intervention":4017,"totalTrials":117,"cells":4019},{"EARLY_PHASE1":4020,"PHASE1":4022,"PHASE2":4024,"PHASE3":4026,"PHASE4":4028,"NA":4030},{"trials":4021,"activeCount":99},[],{"trials":4023,"activeCount":99},[],{"trials":4025,"activeCount":99},[],{"trials":4027,"activeCount":99},[],{"trials":4029,"activeCount":99},[],{"trials":4031,"activeCount":99},[4032],{"nctId":4010,"briefTitle":4011,"status":134,"phases":4033,"primaryCompletion":4013,"completion":2947,"start":4014,"enrollment":154,"conditions":4034,"interventions":4035},[92],[2950],[3995,4017],{"intervention":4037,"totalTrials":117,"cells":4038},"Metformin Hydrochloride 500 MG",{"EARLY_PHASE1":4039,"PHASE1":4041,"PHASE2":4043,"PHASE3":4045,"PHASE4":4047,"NA":4049},{"trials":4040,"activeCount":99},[],{"trials":4042,"activeCount":99},[],{"trials":4044,"activeCount":99},[],{"trials":4046,"activeCount":99},[],{"trials":4048,"activeCount":99},[],{"trials":4050,"activeCount":99},[4051],{"nctId":4052,"briefTitle":4053,"status":134,"phases":4054,"primaryCompletion":2596,"completion":4055,"start":4056,"enrollment":4057,"conditions":4058,"interventions":4060},"NCT07058675","Myoinositol vs. Metformin for Polycystic Ovarian Syndrome (PCOS): Impact on Metabolic Health and Fertility",[92],"2025-06-18","2024-11-25",156,[4059],"PCOS",[4037,4061],"Myoinositol",{"intervention":4061,"totalTrials":117,"cells":4063},{"EARLY_PHASE1":4064,"PHASE1":4066,"PHASE2":4068,"PHASE3":4070,"PHASE4":4072,"NA":4074},{"trials":4065,"activeCount":99},[],{"trials":4067,"activeCount":99},[],{"trials":4069,"activeCount":99},[],{"trials":4071,"activeCount":99},[],{"trials":4073,"activeCount":99},[],{"trials":4075,"activeCount":99},[4076],{"nctId":4052,"briefTitle":4053,"status":134,"phases":4077,"primaryCompletion":2596,"completion":4055,"start":4056,"enrollment":4057,"conditions":4078,"interventions":4079},[92],[4059],[4037,4061],{"intervention":4081,"totalTrials":117,"cells":4082},"Ivermectin",{"EARLY_PHASE1":4083,"PHASE1":4085,"PHASE2":4087,"PHASE3":4089,"PHASE4":4091,"NA":4093},{"trials":4084,"activeCount":99},[],{"trials":4086,"activeCount":99},[],{"trials":4088,"activeCount":99},[],{"trials":4090,"activeCount":99},[],{"trials":4092,"activeCount":99},[],{"trials":4094,"activeCount":99},[4095],{"nctId":4096,"briefTitle":4097,"status":134,"phases":4098,"primaryCompletion":4099,"completion":4100,"start":4101,"enrollment":4102,"conditions":4103,"interventions":4104},"NCT04668469","Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic",[92],"2020-09-15","2020-10-30","2020-06-08",600,[1771],[4081,4105],"Hydroxychloroquine",{"intervention":4105,"totalTrials":117,"cells":4107},{"EARLY_PHASE1":4108,"PHASE1":4110,"PHASE2":4112,"PHASE3":4114,"PHASE4":4116,"NA":4118},{"trials":4109,"activeCount":99},[],{"trials":4111,"activeCount":99},[],{"trials":4113,"activeCount":99},[],{"trials":4115,"activeCount":99},[],{"trials":4117,"activeCount":99},[],{"trials":4119,"activeCount":99},[4120],{"nctId":4096,"briefTitle":4097,"status":134,"phases":4121,"primaryCompletion":4099,"completion":4100,"start":4101,"enrollment":4102,"conditions":4122,"interventions":4123},[92],[1771],[4081,4105],{"intervention":4125,"totalTrials":117,"cells":4126},"Adalimumab",{"EARLY_PHASE1":4127,"PHASE1":4129,"PHASE2":4131,"PHASE3":4133,"PHASE4":4135,"NA":4137},{"trials":4128,"activeCount":99},[],{"trials":4130,"activeCount":99},[],{"trials":4132,"activeCount":99},[],{"trials":4134,"activeCount":99},[],{"trials":4136,"activeCount":99},[],{"trials":4138,"activeCount":99},[4139],{"nctId":4140,"briefTitle":4141,"status":134,"phases":4142,"primaryCompletion":4143,"completion":280,"start":4143,"enrollment":4144,"conditions":4145,"interventions":4147},"NCT07113834","Characteristics of Ankylosing Spondylitis Associated Uveitis",[],"2023-09-01",22,[4146],"Uveitis",[4125,4148],"Systemic corticosteroids",{"intervention":4148,"totalTrials":117,"cells":4150},{"EARLY_PHASE1":4151,"PHASE1":4153,"PHASE2":4155,"PHASE3":4157,"PHASE4":4159,"NA":4161},{"trials":4152,"activeCount":99},[],{"trials":4154,"activeCount":99},[],{"trials":4156,"activeCount":99},[],{"trials":4158,"activeCount":99},[],{"trials":4160,"activeCount":99},[],{"trials":4162,"activeCount":99},[4163],{"nctId":4140,"briefTitle":4141,"status":134,"phases":4164,"primaryCompletion":4143,"completion":280,"start":4143,"enrollment":4144,"conditions":4165,"interventions":4166},[],[4146],[4125,4148],{"intervention":2725,"totalTrials":117,"cells":4168},{"EARLY_PHASE1":4169,"PHASE1":4171,"PHASE2":4173,"PHASE3":4175,"PHASE4":4177,"NA":4179},{"trials":4170,"activeCount":99},[],{"trials":4172,"activeCount":99},[],{"trials":4174,"activeCount":99},[],{"trials":4176,"activeCount":99},[],{"trials":4178,"activeCount":99},[],{"trials":4180,"activeCount":99},[4181],{"nctId":2716,"briefTitle":2717,"status":134,"phases":4182,"primaryCompletion":2643,"completion":2643,"start":2719,"enrollment":2720,"conditions":4183,"interventions":4184},[92],[2711,2722,2723,2690],[2690,2723,2725],{"intervention":2924,"totalTrials":117,"cells":4186},{"EARLY_PHASE1":4187,"PHASE1":4189,"PHASE2":4191,"PHASE3":4193,"PHASE4":4195,"NA":4197},{"trials":4188,"activeCount":99},[],{"trials":4190,"activeCount":99},[],{"trials":4192,"activeCount":99},[],{"trials":4194,"activeCount":99},[],{"trials":4196,"activeCount":99},[],{"trials":4198,"activeCount":99},[4199],{"nctId":2916,"briefTitle":2917,"status":134,"phases":4200,"primaryCompletion":2919,"completion":2919,"start":2920,"enrollment":154,"conditions":4201,"interventions":4202},[92],[2922],[2924,2889],{"intervention":4204,"totalTrials":117,"cells":4205},"0.19 mg fluocinolone acetonide (FAc) implant",{"EARLY_PHASE1":4206,"PHASE1":4208,"PHASE2":4210,"PHASE3":4212,"PHASE4":4214,"NA":4216},{"trials":4207,"activeCount":99},[],{"trials":4209,"activeCount":99},[],{"trials":4211,"activeCount":99},[],{"trials":4213,"activeCount":99},[],{"trials":4215,"activeCount":99},[],{"trials":4217,"activeCount":99},[4218],{"nctId":4219,"briefTitle":4220,"status":278,"phases":4221,"primaryCompletion":4222,"completion":4223,"start":4224,"enrollment":326,"conditions":4225,"interventions":4226},"NCT03590587","Rapid Structural and Functional Improvements in Following 0.19 mg Fluocinolone Acetonide (FAc) Implant in Diabetic Macular Edema Patients With Poor Visual Acuity: 12-month Audit Results From United Arab Emirates",[],"2018-09-15","2018-09-16","2017-01-13",[2657],[4204],{"intervention":306,"totalTrials":117,"cells":4228},{"EARLY_PHASE1":4229,"PHASE1":4231,"PHASE2":4233,"PHASE3":4235,"PHASE4":4237,"NA":4239},{"trials":4230,"activeCount":99},[],{"trials":4232,"activeCount":99},[],{"trials":4234,"activeCount":99},[],{"trials":4236,"activeCount":99},[],{"trials":4238,"activeCount":99},[],{"trials":4240,"activeCount":99},[4241],{"nctId":298,"briefTitle":299,"status":134,"phases":4242,"primaryCompletion":301,"completion":302,"start":303,"enrollment":200,"conditions":4243,"interventions":4244},[92],[18],[306,172,307],{"intervention":307,"totalTrials":117,"cells":4246},{"EARLY_PHASE1":4247,"PHASE1":4249,"PHASE2":4251,"PHASE3":4253,"PHASE4":4255,"NA":4257},{"trials":4248,"activeCount":99},[],{"trials":4250,"activeCount":99},[],{"trials":4252,"activeCount":99},[],{"trials":4254,"activeCount":99},[],{"trials":4256,"activeCount":99},[],{"trials":4258,"activeCount":99},[4259],{"nctId":298,"briefTitle":299,"status":134,"phases":4260,"primaryCompletion":301,"completion":302,"start":303,"enrollment":200,"conditions":4261,"interventions":4262},[92],[18],[306,172,307],{"intervention":4264,"totalTrials":117,"cells":4265},"Low dosage selective alpha-2 receptor agonists topical eyedrop",{"EARLY_PHASE1":4266,"PHASE1":4268,"PHASE2":4270,"PHASE3":4272,"PHASE4":4274,"NA":4276},{"trials":4267,"activeCount":99},[],{"trials":4269,"activeCount":99},[],{"trials":4271,"activeCount":99},[],{"trials":4273,"activeCount":99},[],{"trials":4275,"activeCount":99},[],{"trials":4277,"activeCount":99},[4278],{"nctId":4279,"briefTitle":4280,"status":278,"phases":4281,"primaryCompletion":4282,"completion":2614,"start":4283,"enrollment":1446,"conditions":4284,"interventions":4287},"NCT05670015","Ocular Changes With Alpha-2 Receptor Agonist.",[92],"2023-08-10","2023-01-01",[4285,4286],"Glaucoma, Suspect","Aberration, Corneal Wavefront",[4264,4288],"High dosage selective alpha-2 receptor agonists topical eyedrop",{"intervention":4288,"totalTrials":117,"cells":4290},{"EARLY_PHASE1":4291,"PHASE1":4293,"PHASE2":4295,"PHASE3":4297,"PHASE4":4299,"NA":4301},{"trials":4292,"activeCount":99},[],{"trials":4294,"activeCount":99},[],{"trials":4296,"activeCount":99},[],{"trials":4298,"activeCount":99},[],{"trials":4300,"activeCount":99},[],{"trials":4302,"activeCount":99},[4303],{"nctId":4279,"briefTitle":4280,"status":278,"phases":4304,"primaryCompletion":4282,"completion":2614,"start":4283,"enrollment":1446,"conditions":4305,"interventions":4306},[92],[4285,4286],[4264,4288],{"intervention":4308,"totalTrials":117,"cells":4309},"Total intravenous anesthesia group",{"EARLY_PHASE1":4310,"PHASE1":4312,"PHASE2":4314,"PHASE3":4316,"PHASE4":4318,"NA":4320},{"trials":4311,"activeCount":99},[],{"trials":4313,"activeCount":99},[],{"trials":4315,"activeCount":99},[],{"trials":4317,"activeCount":99},[],{"trials":4319,"activeCount":99},[],{"trials":4321,"activeCount":99},[4322],{"nctId":4323,"briefTitle":4324,"status":134,"phases":4325,"primaryCompletion":4326,"completion":4327,"start":4328,"enrollment":561,"conditions":4329,"interventions":4331},"NCT06423846","Total Intravenous Anesthesia Versus Inhalation Anesthesia on Postoperative Liver Function",[92],"2024-05-06","2024-05-12","2024-01-26",[4330],"Laparoscopic Sleeve Gastrectomy",[4308,4332],"sevoflurane group",{"intervention":4332,"totalTrials":117,"cells":4334},{"EARLY_PHASE1":4335,"PHASE1":4337,"PHASE2":4339,"PHASE3":4341,"PHASE4":4343,"NA":4345},{"trials":4336,"activeCount":99},[],{"trials":4338,"activeCount":99},[],{"trials":4340,"activeCount":99},[],{"trials":4342,"activeCount":99},[],{"trials":4344,"activeCount":99},[],{"trials":4346,"activeCount":99},[4347],{"nctId":4323,"briefTitle":4324,"status":134,"phases":4348,"primaryCompletion":4326,"completion":4327,"start":4328,"enrollment":561,"conditions":4349,"interventions":4350},[92],[4330],[4308,4332],{"intervention":4352,"totalTrials":117,"cells":4353},"Febuxostat 40 milligramsTablet",{"EARLY_PHASE1":4354,"PHASE1":4356,"PHASE2":4358,"PHASE3":4360,"PHASE4":4362,"NA":4364},{"trials":4355,"activeCount":99},[],{"trials":4357,"activeCount":99},[],{"trials":4359,"activeCount":99},[],{"trials":4361,"activeCount":99},[],{"trials":4363,"activeCount":99},[],{"trials":4365,"activeCount":99},[4366],{"nctId":4367,"briefTitle":4368,"status":134,"phases":4369,"primaryCompletion":4370,"completion":1865,"start":2781,"enrollment":4371,"conditions":4372,"interventions":4374},"NCT03149939","Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients",[92],"2017-04-01",19,[4373,3562],"Hyperuricemia",[4352],{"intervention":318,"totalTrials":117,"cells":4376},{"EARLY_PHASE1":4377,"PHASE1":4379,"PHASE2":4381,"PHASE3":4383,"PHASE4":4385,"NA":4387},{"trials":4378,"activeCount":99},[],{"trials":4380,"activeCount":99},[],{"trials":4382,"activeCount":99},[],{"trials":4384,"activeCount":99},[],{"trials":4386,"activeCount":99},[],{"trials":4388,"activeCount":99},[4389],{"nctId":309,"briefTitle":310,"status":134,"phases":4390,"primaryCompletion":312,"completion":313,"start":314,"enrollment":200,"conditions":4391,"interventions":4392},[92],[316],[172,158,318],{"intervention":4394,"totalTrials":117,"cells":4395},"midodrine",{"EARLY_PHASE1":4396,"PHASE1":4398,"PHASE2":4400,"PHASE3":4402,"PHASE4":4404,"NA":4406},{"trials":4397,"activeCount":99},[],{"trials":4399,"activeCount":99},[],{"trials":4401,"activeCount":99},[],{"trials":4403,"activeCount":99},[],{"trials":4405,"activeCount":99},[],{"trials":4407,"activeCount":99},[4408],{"nctId":4409,"briefTitle":4410,"status":134,"phases":4411,"primaryCompletion":4412,"completion":4413,"start":4414,"enrollment":561,"conditions":4415,"interventions":4417},"NCT03431194","Midodrine is Effective in Management of Intradialytic Hypotension Among Critically-ill Patients With Acute Kidney Injury",[92],"2017-02-19","2017-04-06","2016-10-01",[4416],"Acute Kidney Injury",[4394],{"intervention":4419,"totalTrials":117,"cells":4420},"progesterone-only pills",{"EARLY_PHASE1":4421,"PHASE1":4423,"PHASE2":4425,"PHASE3":4427,"PHASE4":4429,"NA":4431},{"trials":4422,"activeCount":99},[],{"trials":4424,"activeCount":99},[],{"trials":4426,"activeCount":99},[],{"trials":4428,"activeCount":99},[],{"trials":4430,"activeCount":99},[],{"trials":4432,"activeCount":99},[4433],{"nctId":4434,"briefTitle":4435,"status":134,"phases":4436,"primaryCompletion":4437,"completion":4438,"start":4439,"enrollment":4440,"conditions":4441,"interventions":4444},"NCT07264933","Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation",[92],"2025-08-05","2026-02-05","2025-02-12",750,[3325,4442,4443,23],"Myometrial Remodeling","Contraceptive Device; Complications",[4419],{"intervention":4446,"totalTrials":117,"cells":4447},"Blood Sampling",{"EARLY_PHASE1":4448,"PHASE1":4450,"PHASE2":4452,"PHASE3":4454,"PHASE4":4456,"NA":4458},{"trials":4449,"activeCount":99},[],{"trials":4451,"activeCount":99},[],{"trials":4453,"activeCount":99},[],{"trials":4455,"activeCount":99},[],{"trials":4457,"activeCount":99},[],{"trials":4459,"activeCount":99},[4460],{"nctId":4461,"briefTitle":4462,"status":134,"phases":4463,"primaryCompletion":4464,"completion":4465,"start":4466,"enrollment":154,"conditions":4467,"interventions":4469},"NCT05449847","Plasma MicroRNA for Prediction of Hepatocellular Carcinoma",[],"2021-12-07","2022-03-20","2021-05-13",[4468],"Hepatitis C",[4446],{"intervention":4471,"totalTrials":117,"cells":4472},"Echinacea Extract",{"EARLY_PHASE1":4473,"PHASE1":4475,"PHASE2":4477,"PHASE3":4479,"PHASE4":4481,"NA":4483},{"trials":4474,"activeCount":99},[],{"trials":4476,"activeCount":99},[],{"trials":4478,"activeCount":99},[],{"trials":4480,"activeCount":99},[],{"trials":4482,"activeCount":99},[],{"trials":4484,"activeCount":99},[4485],{"nctId":4486,"briefTitle":4487,"status":134,"phases":4488,"primaryCompletion":3665,"completion":4489,"start":4490,"enrollment":361,"conditions":4491,"interventions":4492},"NCT06583863","Parasitic Infections and Ulcerative Colitis: Combining Anti-parasitic and Immunomodulatory Treatments May Achieve Remission",[92],"2024-06-12","2023-09-12",[2804],[4471,4493],"MetroNIDAZOLE 500 MG Oral Tablet [Flagyl]",{"intervention":4493,"totalTrials":117,"cells":4495},{"EARLY_PHASE1":4496,"PHASE1":4498,"PHASE2":4500,"PHASE3":4502,"PHASE4":4504,"NA":4506},{"trials":4497,"activeCount":99},[],{"trials":4499,"activeCount":99},[],{"trials":4501,"activeCount":99},[],{"trials":4503,"activeCount":99},[],{"trials":4505,"activeCount":99},[],{"trials":4507,"activeCount":99},[4508],{"nctId":4486,"briefTitle":4487,"status":134,"phases":4509,"primaryCompletion":3665,"completion":4489,"start":4490,"enrollment":361,"conditions":4510,"interventions":4511},[92],[2804],[4471,4493],{"intervention":4513,"totalTrials":117,"cells":4514},"Normal Saline 10 mL",{"EARLY_PHASE1":4515,"PHASE1":4517,"PHASE2":4519,"PHASE3":4521,"PHASE4":4523,"NA":4525},{"trials":4516,"activeCount":99},[],{"trials":4518,"activeCount":99},[],{"trials":4520,"activeCount":99},[],{"trials":4522,"activeCount":99},[],{"trials":4524,"activeCount":99},[],{"trials":4526,"activeCount":99},[4527],{"nctId":4528,"briefTitle":4529,"status":134,"phases":4530,"primaryCompletion":4531,"completion":1993,"start":2708,"enrollment":4532,"conditions":4533,"interventions":4535},"NCT06380764","Greater Occipital Nerve Block Value in Management of Postdural Puncture Headache",[92],"2023-07-25",152,[4534],"Postdural Puncture Headache",[4513,4536],"Lidocaine 2% Injectable Solution",{"intervention":4536,"totalTrials":117,"cells":4538},{"EARLY_PHASE1":4539,"PHASE1":4541,"PHASE2":4543,"PHASE3":4545,"PHASE4":4547,"NA":4549},{"trials":4540,"activeCount":99},[],{"trials":4542,"activeCount":99},[],{"trials":4544,"activeCount":99},[],{"trials":4546,"activeCount":99},[],{"trials":4548,"activeCount":99},[],{"trials":4550,"activeCount":99},[4551],{"nctId":4528,"briefTitle":4529,"status":134,"phases":4552,"primaryCompletion":4531,"completion":1993,"start":2708,"enrollment":4532,"conditions":4553,"interventions":4554},[92],[4534],[4513,4536],{"intervention":330,"totalTrials":117,"cells":4556},{"EARLY_PHASE1":4557,"PHASE1":4559,"PHASE2":4561,"PHASE3":4563,"PHASE4":4565,"NA":4567},{"trials":4558,"activeCount":99},[],{"trials":4560,"activeCount":99},[],{"trials":4562,"activeCount":99},[],{"trials":4564,"activeCount":99},[],{"trials":4566,"activeCount":99},[],{"trials":4568,"activeCount":99},[4569],{"nctId":320,"briefTitle":321,"status":134,"phases":4570,"primaryCompletion":323,"completion":324,"start":325,"enrollment":326,"conditions":4571,"interventions":4572},[92],[328],[172,330,331],{"intervention":4574,"totalTrials":117,"cells":4575},"Intralesional treatment with Hyaluronic acid",{"EARLY_PHASE1":4576,"PHASE1":4578,"PHASE2":4580,"PHASE3":4582,"PHASE4":4584,"NA":4586},{"trials":4577,"activeCount":99},[],{"trials":4579,"activeCount":99},[],{"trials":4581,"activeCount":99},[],{"trials":4583,"activeCount":99},[],{"trials":4585,"activeCount":99},[],{"trials":4587,"activeCount":99},[4588],{"nctId":4589,"briefTitle":4590,"status":278,"phases":4591,"primaryCompletion":4592,"completion":4592,"start":4593,"enrollment":960,"conditions":4594,"interventions":4598},"NCT05855070","Intralesional Hyaluronic Acid and Verapamil Injection in Peyronie's Disease",[92],"2024-05-20","2023-05-20",[4595,4596,4597],"Peyronie's Disease","Hyaluronic Acid","Verapamil",[4574,4599],"Intralesional treatment with Verapamil",{"intervention":4599,"totalTrials":117,"cells":4601},{"EARLY_PHASE1":4602,"PHASE1":4604,"PHASE2":4606,"PHASE3":4608,"PHASE4":4610,"NA":4612},{"trials":4603,"activeCount":99},[],{"trials":4605,"activeCount":99},[],{"trials":4607,"activeCount":99},[],{"trials":4609,"activeCount":99},[],{"trials":4611,"activeCount":99},[],{"trials":4613,"activeCount":99},[4614],{"nctId":4589,"briefTitle":4590,"status":278,"phases":4615,"primaryCompletion":4592,"completion":4592,"start":4593,"enrollment":960,"conditions":4616,"interventions":4617},[92],[4595,4596,4597],[4574,4599]]